data_1kvf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kvf _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 CA--C 1.524 -0.037 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -140.94 164.05 31.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.038 1.735 . . . . 0.0 110.041 -170.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -85.01 113.52 21.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.28 156.35 7.36 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.23 -46.32 0.37 Allowed 'Cis proline' 0 N--CA 1.458 -0.591 0 CA-C-N 118.769 1.285 . . . . 0.0 111.991 4.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.6 tp -99.96 -60.23 1.57 Allowed 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.37 1.068 . . . . 0.0 108.96 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 63.9 p -99.69 -174.59 2.75 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.95 1.3 . . . . 0.0 109.017 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -73.06 144.64 47.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 169.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.1 t -131.45 133.75 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.343 0.301 0 C-N-CA 124.418 1.087 . . . . 0.0 110.646 -176.539 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.3 m . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -140.34 152.65 45.98 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.216 1.406 . . . . 0.0 110.099 -170.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -86.96 80.87 8.29 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.46 171.15 43.42 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.97 -34.61 1.14 Allowed 'Cis proline' 0 N--CA 1.46 -0.482 0 CA-C-N 119.495 1.648 . . . . 0.0 113.515 -0.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.2 tp -121.72 -55.17 1.92 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.719 1.208 . . . . 0.0 109.889 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.5 p -99.56 176.75 5.38 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.548 1.139 . . . . 0.0 111.026 -170.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -70.31 101.58 1.95 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.543 0.737 . . . . 0.0 109.87 173.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.4 t -99.82 106.67 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 125.397 1.479 . . . . 0.0 108.545 175.008 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.456 -0.16 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -140.3 141.49 35.76 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.748 1.219 . . . . 0.0 110.157 -169.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -84.96 77.0 10.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.42 165.6 38.99 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -62.19 -34.74 1.51 Allowed 'Cis proline' 0 C--N 1.346 0.414 0 CA-C-N 119.688 1.744 . . . . 0.0 113.729 1.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.1 tp -123.72 -55.96 1.7 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.709 1.204 . . . . 0.0 109.389 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.6 p -99.38 178.76 4.79 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.704 1.202 . . . . 0.0 110.193 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -65.24 121.68 15.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.655 0.382 . . . . 0.0 110.252 172.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.75 149.51 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.454 -0.254 0 C-N-CA 122.413 0.285 . . . . 0.0 111.031 -177.194 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 96.2 m . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -140.55 169.69 17.18 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.214 1.406 . . . . 0.0 110.206 -172.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -92.73 118.56 31.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.82 152.2 6.22 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.49 -45.92 0.39 Allowed 'Cis proline' 0 N--CA 1.457 -0.674 0 CA-C-N 118.888 1.344 . . . . 0.0 111.249 -0.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.6 tp -104.83 -42.22 5.42 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.202 1.401 . . . . 0.0 110.214 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.1 p -116.53 -179.83 3.79 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.18 1.392 . . . . 0.0 109.827 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -75.5 136.36 40.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -138.61 136.59 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.103 0.961 . . . . 0.0 109.297 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 N--CA 1.455 -0.207 0 C-N-CA 125.112 1.365 . . . . 0.0 108.651 169.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -140.42 144.47 36.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.706 1.202 . . . . 0.0 110.152 -170.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -85.82 66.37 9.59 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.53 153.58 25.33 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.79 -18.57 17.12 Favored 'Cis proline' 0 N--CA 1.458 -0.562 0 CA-C-N 119.186 1.493 . . . . 0.0 112.517 1.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.3 tp -139.97 -52.66 0.52 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.639 1.176 . . . . 0.0 109.226 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 p -99.35 177.0 5.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.7 1.2 . . . . 0.0 110.023 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -68.95 115.8 8.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.977 0.511 . . . . 0.0 110.267 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.66 146.25 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.453 -0.298 0 C-N-CA 122.434 0.293 . . . . 0.0 111.0 -177.147 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -140.46 167.62 21.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.714 1.206 . . . . 0.0 110.197 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -84.28 100.71 11.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 169.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.77 164.23 15.34 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.05 -47.84 0.29 Allowed 'Cis proline' 0 N--CA 1.46 -0.474 0 CA-C-N 119.14 1.47 . . . . 0.0 112.965 3.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tt -104.02 -59.69 1.69 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.583 1.153 . . . . 0.0 108.357 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.8 p -99.37 -176.64 3.35 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.88 1.272 . . . . 0.0 109.088 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -71.9 132.57 44.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.26 149.54 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.703 0.801 . . . . 0.0 109.243 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 N--CA 1.455 -0.188 0 C-N-CA 125.415 1.486 . . . . 0.0 108.689 171.82 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.457 -0.078 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -140.3 161.5 37.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.037 1.335 . . . . 0.0 110.202 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -98.29 98.74 9.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.15 143.42 8.46 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.57 -46.12 0.31 Allowed 'Cis proline' 0 C--N 1.347 0.459 0 CA-C-N 119.691 1.745 . . . . 0.0 111.607 -5.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 tp -140.46 36.08 1.85 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.273 1.029 . . . . 0.0 108.765 169.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -140.74 139.44 34.66 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.996 1.318 . . . . 0.0 109.257 -171.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -73.58 98.59 2.86 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.1 t -99.63 103.06 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.339 0.127 0 C-N-CA 125.178 1.391 . . . . 0.0 108.622 179.018 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -140.38 166.38 24.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.807 1.643 . . . . 0.0 109.899 -173.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -91.84 106.62 18.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.37 161.91 12.26 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.0 -40.34 1.23 Allowed 'Cis proline' 0 N--CA 1.456 -0.721 0 CA-C-N 118.727 1.264 . . . . 0.0 111.755 2.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.7 tp -104.17 -56.43 2.19 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.533 1.133 . . . . 0.0 109.682 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.2 p -107.31 -176.5 3.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.067 1.347 . . . . 0.0 110.236 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -67.18 139.41 57.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.8 t -138.64 126.54 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 t . . . . . 0 C--N 1.341 0.231 0 C-N-CA 124.716 1.207 . . . . 0.0 109.132 176.617 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 98.3 m . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -140.95 165.07 28.55 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.21 1.004 . . . . 0.0 111.526 -170.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -90.82 119.23 30.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.46 156.37 7.39 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.34 -44.64 0.48 Allowed 'Cis proline' 0 N--CA 1.456 -0.705 0 CA-C-N 118.682 1.241 . . . . 0.0 111.56 1.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tt -104.34 -55.97 2.27 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.964 1.306 . . . . 0.0 108.258 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.0 p -99.58 -176.56 3.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.068 1.347 . . . . 0.0 109.504 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -76.74 138.18 39.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 171.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.8 t -137.93 147.17 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.452 -0.334 0 C-N-CA 122.916 0.486 . . . . 0.0 110.678 174.885 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -125.19 138.23 54.13 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.741 1.216 . . . . 0.0 108.998 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -82.9 70.11 9.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.197 0.599 . . . . 0.0 109.893 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.96 148.43 16.91 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.97 -16.37 21.19 Favored 'Cis proline' 0 N--CA 1.459 -0.545 0 CA-C-N 119.32 1.56 . . . . 0.0 112.751 3.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 tp -140.05 -54.63 0.54 Allowed 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.236 1.014 . . . . 0.0 109.576 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.3 p -99.32 173.81 6.59 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.512 1.125 . . . . 0.0 110.615 -172.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -69.17 102.88 1.77 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.401 0.681 . . . . 0.0 109.63 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.52 118.26 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 125.103 1.361 . . . . 0.0 109.606 -175.534 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -140.08 139.59 35.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.856 1.262 . . . . 0.0 109.985 -169.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -85.04 60.5 6.29 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.452 0.701 . . . . 0.0 110.096 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.95 129.77 7.96 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.099 1.333 . . . . 0.0 109.983 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.65 -49.42 0.23 Allowed 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.941 1.871 . . . . 0.0 111.073 -0.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -140.9 33.58 1.77 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.103 0.961 . . . . 0.0 109.189 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.4 p -140.68 147.81 39.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.089 1.356 . . . . 0.0 108.506 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -72.9 93.15 1.68 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.755 0.422 . . . . 0.0 110.367 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.8 t -99.71 137.76 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.108 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -140.41 165.82 26.38 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.925 1.29 . . . . 0.0 110.576 -172.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -84.3 137.8 33.25 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.52 174.73 31.13 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.93 1.252 . . . . 0.0 110.808 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -60.87 -47.62 0.2 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.502 0 CA-C-N 118.822 1.311 . . . . 0.0 114.016 5.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 tt -102.18 -64.84 1.03 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.1 0.96 . . . . 0.0 108.85 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.6 p -99.56 -175.67 3.06 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.802 1.241 . . . . 0.0 109.212 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -69.6 139.28 53.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.3 t -140.04 145.04 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.311 1.044 . . . . 0.0 108.754 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m . . . . . 0 C--N 1.339 0.148 0 C-N-CA 124.393 1.077 . . . . 0.0 110.842 175.297 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -140.31 172.82 12.2 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.241 1.417 . . . . 0.0 110.405 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -103.26 114.96 29.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.91 0.884 . . . . 0.0 108.779 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.49 140.31 3.49 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.73 -45.06 0.48 Allowed 'Cis proline' 0 N--CA 1.458 -0.575 0 CA-C-N 119.712 1.756 . . . . 0.0 111.457 1.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.0 tp -140.22 25.41 2.26 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.212 1.005 . . . . 0.0 109.842 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.8 p -140.62 159.85 41.3 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.409 1.483 . . . . 0.0 108.319 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -76.93 125.76 29.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.76 147.54 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.679 1.191 . . . . 0.0 108.461 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 CA--C 1.53 0.195 0 C-N-CA 124.055 0.942 . . . . 0.0 109.456 175.61 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.7 m . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -140.73 163.76 32.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.116 1.366 . . . . 0.0 110.612 -170.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -89.12 116.44 27.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.9 156.8 7.3 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.14 -44.71 0.48 Allowed 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 118.647 1.223 . . . . 0.0 111.772 3.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.0 tp -102.03 -58.12 1.94 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.591 1.157 . . . . 0.0 109.113 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.4 p -99.88 -176.32 3.22 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.893 1.277 . . . . 0.0 109.543 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -74.81 139.31 43.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.21 152.51 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.273 1.029 . . . . 0.0 108.553 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 90.3 m . . . . . 0 C--N 1.34 0.171 0 C-N-CA 124.361 1.064 . . . . 0.0 110.213 172.829 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.2 m . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -140.48 162.48 35.24 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.015 1.326 . . . . 0.0 110.065 -172.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -85.65 111.18 19.85 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.7 155.19 7.08 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.18 -43.14 0.64 Allowed 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 118.726 1.263 . . . . 0.0 112.02 4.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tt -105.42 -58.32 1.91 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.629 1.171 . . . . 0.0 108.221 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.0 p -99.56 -178.76 3.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.038 1.335 . . . . 0.0 109.528 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -74.38 139.84 44.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 72.8 t -136.19 130.25 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.975 0.91 . . . . 0.0 109.317 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.455 -0.177 0 C-N-CA 125.576 1.55 . . . . 0.0 107.397 169.343 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.1 m . . . . . 0 C--O 1.23 0.077 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -140.52 167.78 21.35 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.606 1.562 . . . . 0.0 110.004 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -92.7 106.55 18.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.13 159.05 10.17 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.8 -39.94 1.31 Allowed 'Cis proline' 0 N--CA 1.456 -0.678 0 CA-C-N 118.674 1.237 . . . . 0.0 111.842 2.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.9 tp -105.86 -46.33 4.15 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.615 1.166 . . . . 0.0 110.42 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.4 p -122.02 -178.65 3.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.058 1.343 . . . . 0.0 110.286 -174.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -66.79 131.09 45.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.155 0.582 . . . . 0.0 110.194 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.9 t -132.24 119.16 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.9 t . . . . . 0 C--N 1.342 0.248 0 C-N-CA 124.402 1.081 . . . . 0.0 110.274 177.508 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 92.9 m . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -140.28 164.65 29.5 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.032 1.333 . . . . 0.0 110.556 -170.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -89.05 87.08 7.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.31 174.11 41.63 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.36 -41.27 0.47 Allowed 'Cis proline' 0 N--CA 1.46 -0.462 0 CA-C-N 119.312 1.556 . . . . 0.0 113.593 1.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.6 tp -113.14 -59.19 2.05 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.619 1.168 . . . . 0.0 109.572 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.7 p -99.73 179.81 4.42 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.945 1.298 . . . . 0.0 110.097 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -66.74 131.33 45.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.7 0.4 . . . . 0.0 110.498 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.5 t -133.15 118.89 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 C--N 1.34 0.174 0 C-N-CA 124.988 1.315 . . . . 0.0 108.797 173.906 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -140.31 175.14 9.84 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.73 1.212 . . . . 0.0 110.359 -170.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -105.98 113.27 26.71 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.31 1.044 . . . . 0.0 108.868 170.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.59 141.0 4.78 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.48 -44.26 0.58 Allowed 'Cis proline' 0 N--CA 1.458 -0.617 0 CA-C-N 119.58 1.69 . . . . 0.0 111.189 -1.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 tp -140.17 26.54 2.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.302 1.041 . . . . 0.0 109.709 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.6 p -140.78 154.28 46.2 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.532 1.533 . . . . 0.0 108.29 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -74.19 127.92 34.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -136.58 135.04 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.499 1.12 . . . . 0.0 108.908 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.455 -0.199 0 C-N-CA 124.624 1.17 . . . . 0.0 109.015 170.496 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.1 m . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -100.02 145.9 27.36 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.184 1.393 . . . . 0.0 110.075 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -85.76 76.14 9.97 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.485 0.714 . . . . 0.0 109.429 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.29 152.56 21.75 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.38 -13.82 24.35 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 118.983 1.391 . . . . 0.0 112.752 2.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.3 tp -140.08 -54.87 0.54 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.237 1.015 . . . . 0.0 109.517 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.8 p -99.58 175.87 5.68 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.571 1.148 . . . . 0.0 110.768 -173.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -71.54 100.61 2.29 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.578 0.751 . . . . 0.0 109.148 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.8 t -99.73 114.03 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.34 0.156 0 C-N-CA 124.377 1.071 . . . . 0.0 109.847 174.776 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.0 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -140.61 164.18 30.85 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.314 1.046 . . . . 0.0 110.503 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -79.23 84.99 5.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.09 176.5 39.18 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -58.91 -50.94 0.14 OUTLIER 'Cis proline' 0 CA--C 1.532 0.403 0 CA-C-N 119.037 1.419 . . . . 0.0 114.504 4.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 tp -103.06 -64.73 1.05 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.233 1.013 . . . . 0.0 109.295 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.2 p -99.58 -179.87 4.33 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.848 1.259 . . . . 0.0 108.244 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -68.13 123.58 21.07 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.017 -0.427 . . . . 0.0 110.629 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.3 t -139.06 148.22 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.4 m . . . . . 0 N--CA 1.455 -0.193 0 C-N-CA 123.904 0.881 . . . . 0.0 109.438 176.049 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.9 p . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.451 0.167 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -74.04 159.27 32.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.886 0.874 . . . . 0.0 110.967 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.9 t -99.39 68.62 1.62 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m -111.63 91.35 3.63 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.856 1.663 . . . . 0.0 109.033 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -140.94 164.05 31.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.038 1.735 . . . . 0.0 110.041 -170.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -85.01 113.52 21.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.28 156.35 7.36 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.23 -46.32 0.37 Allowed 'Cis proline' 0 N--CA 1.458 -0.591 0 CA-C-N 118.769 1.285 . . . . 0.0 111.991 4.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.6 tp -99.96 -60.23 1.57 Allowed 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.37 1.068 . . . . 0.0 108.96 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 63.9 p -99.69 -174.59 2.75 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.95 1.3 . . . . 0.0 109.017 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -73.06 144.64 47.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 169.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.1 t -131.45 133.75 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.5 t -140.12 91.43 2.45 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.418 1.087 . . . . 0.0 110.646 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -99.85 119.21 60.27 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.558 1.143 . . . . 0.0 108.42 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.12 84.5 2.03 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.109 2.54 . . . . 0.0 110.15 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -63.05 -64.41 0.92 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.692 0.797 . . . . 0.0 111.086 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.084 0 O-C-N 122.103 -0.373 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.4 p . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 120.387 0.137 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -81.05 60.73 4.34 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.893 0.877 . . . . 0.0 109.885 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -99.94 -178.9 3.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.706 1.202 . . . . 0.0 109.31 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.3 m -109.79 86.3 2.27 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.464 1.505 . . . . 0.0 108.431 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -140.34 152.65 45.98 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.216 1.406 . . . . 0.0 110.099 -170.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -86.96 80.87 8.29 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.46 171.15 43.42 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.97 -34.61 1.14 Allowed 'Cis proline' 0 N--CA 1.46 -0.482 0 CA-C-N 119.495 1.648 . . . . 0.0 113.515 -0.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.2 tp -121.72 -55.17 1.92 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.719 1.208 . . . . 0.0 109.889 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.5 p -99.56 176.75 5.38 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.548 1.139 . . . . 0.0 111.026 -170.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -70.31 101.58 1.95 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.543 0.737 . . . . 0.0 109.87 173.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.4 t -99.82 106.67 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t -140.18 71.61 1.38 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.397 1.479 . . . . 0.0 108.545 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -125.31 74.41 68.02 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 125.014 1.325 . . . . 0.0 108.177 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.53 109.49 2.28 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.012 2.475 . . . . 0.0 110.371 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -68.86 -50.73 47.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.88 0.872 . . . . 0.0 110.592 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.031 0 O-C-N 122.231 -0.293 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 111.174 0.064 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -66.21 152.0 45.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.435 0.694 . . . . 0.0 110.954 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -99.47 99.78 10.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.013 1.325 . . . . 0.0 108.502 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.6 m -99.83 132.16 45.35 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.149 0.98 . . . . 0.0 109.49 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -140.3 141.49 35.76 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.748 1.219 . . . . 0.0 110.157 -169.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -84.96 77.0 10.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.42 165.6 38.99 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -62.19 -34.74 1.51 Allowed 'Cis proline' 0 C--N 1.346 0.414 0 CA-C-N 119.688 1.744 . . . . 0.0 113.729 1.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.1 tp -123.72 -55.96 1.7 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.709 1.204 . . . . 0.0 109.389 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.6 p -99.38 178.76 4.79 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.704 1.202 . . . . 0.0 110.193 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -65.24 121.68 15.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.655 0.382 . . . . 0.0 110.252 172.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.75 149.51 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.4 t -140.16 144.69 36.78 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.413 0.285 . . . . 0.0 111.031 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -140.24 170.93 8.6 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.591 1.556 . . . . 0.0 108.975 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.79 167.11 2.39 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.33 2.687 . . . . 0.0 113.698 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -54.35 -55.63 26.58 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.398 1.079 . . . . 0.0 111.554 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.056 0 O-C-N 122.313 -0.242 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.9 p . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 119.854 -0.117 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -72.29 87.68 1.14 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.116 0.966 . . . . 0.0 109.322 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.5 m -99.55 99.39 10.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.782 1.233 . . . . 0.0 108.876 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 96.2 m -99.07 114.23 26.83 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.247 1.419 . . . . 0.0 109.099 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -140.55 169.69 17.18 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.214 1.406 . . . . 0.0 110.206 -172.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -92.73 118.56 31.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.82 152.2 6.22 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.49 -45.92 0.39 Allowed 'Cis proline' 0 N--CA 1.457 -0.674 0 CA-C-N 118.888 1.344 . . . . 0.0 111.249 -0.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.6 tp -104.83 -42.22 5.42 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.202 1.401 . . . . 0.0 110.214 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.1 p -116.53 -179.83 3.79 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.18 1.392 . . . . 0.0 109.827 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -75.5 136.36 40.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -138.61 136.59 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.103 0.961 . . . . 0.0 109.297 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.0 m -108.81 122.56 47.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.112 1.365 . . . . 0.0 108.651 169.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -99.71 109.16 54.58 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -67.81 -52.75 0.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.134 2.556 . . . . 0.0 111.494 -170.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 65.83 -73.31 0.07 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.543 1.937 . . . . 0.0 112.995 170.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.093 0 O-C-N 121.885 -0.51 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 120.005 -0.045 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -80.63 75.24 7.53 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.946 0.898 . . . . 0.0 108.875 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 p -99.44 100.05 11.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.843 1.257 . . . . 0.0 109.078 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.3 m -99.73 129.07 45.82 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.649 1.18 . . . . 0.0 109.232 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -140.42 144.47 36.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.706 1.202 . . . . 0.0 110.152 -170.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -85.82 66.37 9.59 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.53 153.58 25.33 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.79 -18.57 17.12 Favored 'Cis proline' 0 N--CA 1.458 -0.562 0 CA-C-N 119.186 1.493 . . . . 0.0 112.517 1.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.3 tp -139.97 -52.66 0.52 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.639 1.176 . . . . 0.0 109.226 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 p -99.35 177.0 5.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.7 1.2 . . . . 0.0 110.023 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -68.95 115.8 8.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.977 0.511 . . . . 0.0 110.267 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.66 146.25 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.0 t -140.1 137.85 34.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.434 0.293 . . . . 0.0 111.0 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -102.93 109.5 61.48 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.51 -53.84 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.621 2.214 . . . . 0.0 111.159 -173.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 67.4 -67.62 0.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.617 1.967 . . . . 0.0 112.605 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.093 0 O-C-N 121.781 -0.574 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 110.864 -0.05 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -54.56 147.44 14.23 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.223 1.009 . . . . 0.0 111.847 -174.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.3 p -99.37 98.05 9.03 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.283 1.433 . . . . 0.0 108.259 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.1 m -99.21 113.9 26.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.504 1.522 . . . . 0.0 109.013 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -140.46 167.62 21.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.714 1.206 . . . . 0.0 110.197 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -84.28 100.71 11.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 169.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.77 164.23 15.34 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.05 -47.84 0.29 Allowed 'Cis proline' 0 N--CA 1.46 -0.474 0 CA-C-N 119.14 1.47 . . . . 0.0 112.965 3.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tt -104.02 -59.69 1.69 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.583 1.153 . . . . 0.0 108.357 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.8 p -99.37 -176.64 3.35 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.88 1.272 . . . . 0.0 109.088 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -71.9 132.57 44.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.26 149.54 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.703 0.801 . . . . 0.0 109.243 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.4 m -110.36 118.04 35.23 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.415 1.486 . . . . 0.0 108.689 171.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -99.67 146.43 31.82 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 109.245 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.0 133.76 37.05 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.256 2.637 . . . . 0.0 110.509 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.6 134.39 11.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.05 0 O-C-N 122.135 -0.353 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.61 0.243 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -82.27 47.81 1.19 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.912 0.885 . . . . 0.0 109.923 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 m -141.08 165.76 26.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.155 1.382 . . . . 0.0 109.46 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.3 m -107.1 92.33 4.03 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.961 1.304 . . . . 0.0 109.303 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -140.3 161.5 37.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.037 1.335 . . . . 0.0 110.202 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -98.29 98.74 9.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.15 143.42 8.46 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.57 -46.12 0.31 Allowed 'Cis proline' 0 C--N 1.347 0.459 0 CA-C-N 119.691 1.745 . . . . 0.0 111.607 -5.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 tp -140.46 36.08 1.85 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.273 1.029 . . . . 0.0 108.765 169.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -140.74 139.44 34.66 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.996 1.318 . . . . 0.0 109.257 -171.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -73.58 98.59 2.86 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.1 t -99.63 103.06 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -140.4 61.88 1.51 Allowed 'General case' 0 C--N 1.339 0.127 0 C-N-CA 125.178 1.391 . . . . 0.0 108.622 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -140.27 148.06 52.56 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.071 1.348 . . . . 0.0 108.465 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.03 72.25 6.61 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.555 2.837 . . . . 0.0 110.011 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.39 -21.98 2.52 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.603 1.161 . . . . 0.0 112.172 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.044 0 O-C-N 121.654 -0.654 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 57.1 m . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 120.232 0.063 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -66.11 162.24 20.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.181 0.992 . . . . 0.0 110.531 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 t -98.81 67.92 1.72 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m -99.92 84.74 2.93 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.675 1.59 . . . . 0.0 109.423 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -140.38 166.38 24.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.807 1.643 . . . . 0.0 109.899 -173.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -91.84 106.62 18.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.37 161.91 12.26 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.0 -40.34 1.23 Allowed 'Cis proline' 0 N--CA 1.456 -0.721 0 CA-C-N 118.727 1.264 . . . . 0.0 111.755 2.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.7 tp -104.17 -56.43 2.19 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.533 1.133 . . . . 0.0 109.682 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.2 p -107.31 -176.5 3.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.067 1.347 . . . . 0.0 110.236 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -67.18 139.41 57.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.8 t -138.64 126.54 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 t -140.66 100.45 3.86 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.716 1.207 . . . . 0.0 109.132 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -140.33 162.83 47.57 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 125.698 1.599 . . . . 0.0 109.596 -170.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.53 154.42 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.631 2.887 . . . . 0.0 112.889 170.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.59 -52.68 64.44 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.838 0.855 . . . . 0.0 111.239 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.086 0 O-C-N 122.327 -0.233 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.709 -0.108 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -84.41 74.74 10.32 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.028 0.931 . . . . 0.0 108.817 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.8 p -99.42 98.25 9.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.939 0.895 . . . . 0.0 110.081 -169.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.85 117.85 35.03 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.851 1.26 . . . . 0.0 108.382 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -140.95 165.07 28.55 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.21 1.004 . . . . 0.0 111.526 -170.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -90.82 119.23 30.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.46 156.37 7.39 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.34 -44.64 0.48 Allowed 'Cis proline' 0 N--CA 1.456 -0.705 0 CA-C-N 118.682 1.241 . . . . 0.0 111.56 1.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tt -104.34 -55.97 2.27 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.964 1.306 . . . . 0.0 108.258 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.0 p -99.58 -176.56 3.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.068 1.347 . . . . 0.0 109.504 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -76.74 138.18 39.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 171.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.8 t -137.93 147.17 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.44 145.02 44.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.916 0.486 . . . . 0.0 110.678 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.27 86.24 17.2 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -81.71 65.05 8.62 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.442 2.761 . . . . 0.0 110.171 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -107.72 150.07 27.39 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.583 1.153 . . . . 0.0 110.296 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.088 0 O-C-N 122.208 -0.308 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 N--CA 1.474 0.772 0 CA-C-O 120.355 0.122 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -74.93 72.17 2.09 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.499 1.12 . . . . 0.0 109.107 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m -140.38 -163.64 1.56 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.746 1.619 . . . . 0.0 109.109 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.2 m -101.96 149.98 23.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.621 0.768 . . . . 0.0 109.706 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -125.19 138.23 54.13 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.741 1.216 . . . . 0.0 108.998 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -82.9 70.11 9.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.197 0.599 . . . . 0.0 109.893 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.96 148.43 16.91 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.97 -16.37 21.19 Favored 'Cis proline' 0 N--CA 1.459 -0.545 0 CA-C-N 119.32 1.56 . . . . 0.0 112.751 3.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 tp -140.05 -54.63 0.54 Allowed 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.236 1.014 . . . . 0.0 109.576 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.3 p -99.32 173.81 6.59 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.512 1.125 . . . . 0.0 110.615 -172.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -69.17 102.88 1.77 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.401 0.681 . . . . 0.0 109.63 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.52 118.26 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.2 m -99.83 109.81 22.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.103 1.361 . . . . 0.0 109.606 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -140.03 154.65 70.6 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.979 1.312 . . . . 0.0 109.076 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.53 77.48 3.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.506 2.804 . . . . 0.0 109.959 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -68.57 -58.25 4.55 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.453 0.701 . . . . 0.0 109.823 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.06 0 CA-C-N 116.672 -0.24 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 120.282 0.087 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -79.77 72.93 6.51 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.724 1.21 . . . . 0.0 109.409 -176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.0 m -99.83 -178.84 3.99 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.624 1.17 . . . . 0.0 110.189 -175.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m -99.32 132.57 44.55 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -140.08 139.59 35.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.856 1.262 . . . . 0.0 109.985 -169.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -85.04 60.5 6.29 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.452 0.701 . . . . 0.0 110.096 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.95 129.77 7.96 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.099 1.333 . . . . 0.0 109.983 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.65 -49.42 0.23 Allowed 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.941 1.871 . . . . 0.0 111.073 -0.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -140.9 33.58 1.77 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.103 0.961 . . . . 0.0 109.189 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.4 p -140.68 147.81 39.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.089 1.356 . . . . 0.0 108.506 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -72.9 93.15 1.68 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.755 0.422 . . . . 0.0 110.367 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.8 t -99.71 137.76 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.6 t -140.06 72.45 1.4 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -124.02 162.69 39.98 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.084 1.754 . . . . 0.0 108.397 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -49.98 110.02 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.795 2.997 . . . . 0.0 113.217 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -78.75 -58.86 3.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.913 0.885 . . . . 0.0 110.202 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.055 0 O-C-N 122.214 -0.304 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 47.4 p . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 120.254 0.073 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -155.28 175.17 14.21 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.56 1.144 . . . . 0.0 109.861 177.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 t -140.16 171.46 14.15 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.349 1.06 . . . . 0.0 109.526 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.0 m -140.1 155.37 47.04 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.246 1.019 . . . . 0.0 109.971 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -140.41 165.82 26.38 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.925 1.29 . . . . 0.0 110.576 -172.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -84.3 137.8 33.25 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.52 174.73 31.13 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.93 1.252 . . . . 0.0 110.808 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -60.87 -47.62 0.2 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.502 0 CA-C-N 118.822 1.311 . . . . 0.0 114.016 5.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 tt -102.18 -64.84 1.03 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.1 0.96 . . . . 0.0 108.85 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.6 p -99.56 -175.67 3.06 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.802 1.241 . . . . 0.0 109.212 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -69.6 139.28 53.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.3 t -140.04 145.04 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.311 1.044 . . . . 0.0 108.754 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -101.61 150.94 22.58 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.393 1.077 . . . . 0.0 110.842 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -118.92 75.76 13.96 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.142 1.377 . . . . 0.0 108.89 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.35 107.92 1.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.309 2.673 . . . . 0.0 110.295 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -69.92 -52.83 21.34 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.809 0.844 . . . . 0.0 110.364 -177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.03 0 O-C-N 122.285 -0.259 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -179.07 176.38 0.89 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 125.53 1.532 . . . . 0.0 109.573 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.1 t -138.83 116.82 11.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.6 m -99.44 124.33 44.49 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -140.31 172.82 12.2 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.241 1.417 . . . . 0.0 110.405 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -103.26 114.96 29.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.91 0.884 . . . . 0.0 108.779 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.49 140.31 3.49 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.73 -45.06 0.48 Allowed 'Cis proline' 0 N--CA 1.458 -0.575 0 CA-C-N 119.712 1.756 . . . . 0.0 111.457 1.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.0 tp -140.22 25.41 2.26 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.212 1.005 . . . . 0.0 109.842 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.8 p -140.62 159.85 41.3 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.409 1.483 . . . . 0.0 108.319 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -76.93 125.76 29.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.76 147.54 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.679 1.191 . . . . 0.0 108.461 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.3 t -140.44 161.29 38.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.055 0.942 . . . . 0.0 109.456 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -129.46 77.69 76.9 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.053 0.941 . . . . 0.0 112.29 -169.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -47.19 120.98 4.75 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.227 3.285 . . . . 0.0 111.928 170.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -153.07 168.86 24.5 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.737 0.815 . . . . 0.0 110.578 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.087 0 O-C-N 122.128 -0.357 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.29 0.091 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -112.97 85.46 2.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.299 1.44 . . . . 0.0 107.793 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.2 t -98.96 95.15 6.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -170.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.7 m -99.32 116.99 32.77 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.5 1.52 . . . . 0.0 108.672 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -140.73 163.76 32.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.116 1.366 . . . . 0.0 110.612 -170.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -89.12 116.44 27.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.9 156.8 7.3 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.14 -44.71 0.48 Allowed 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 118.647 1.223 . . . . 0.0 111.772 3.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.0 tp -102.03 -58.12 1.94 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.591 1.157 . . . . 0.0 109.113 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.4 p -99.88 -176.32 3.22 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.893 1.277 . . . . 0.0 109.543 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -74.81 139.31 43.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.21 152.51 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.273 1.029 . . . . 0.0 108.553 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 90.3 m -122.71 151.51 41.48 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.361 1.064 . . . . 0.0 110.213 172.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -125.6 89.65 52.07 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.165 1.386 . . . . 0.0 108.65 172.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -64.24 175.69 3.12 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.076 3.184 . . . . 0.0 112.587 172.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -77.57 71.42 4.06 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 170.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.077 0 O-C-N 122.145 -0.347 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 111.369 0.137 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -98.34 168.05 10.46 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.142 0.977 . . . . 0.0 109.98 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -99.39 87.78 3.71 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.2 m -98.93 105.3 17.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.313 1.445 . . . . 0.0 107.924 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -140.48 162.48 35.24 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.015 1.326 . . . . 0.0 110.065 -172.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -85.65 111.18 19.85 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.7 155.19 7.08 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.18 -43.14 0.64 Allowed 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 118.726 1.263 . . . . 0.0 112.02 4.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tt -105.42 -58.32 1.91 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.629 1.171 . . . . 0.0 108.221 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.0 p -99.56 -178.76 3.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.038 1.335 . . . . 0.0 109.528 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -74.38 139.84 44.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 72.8 t -136.19 130.25 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.975 0.91 . . . . 0.0 109.317 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.7 m -105.3 103.41 12.94 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.576 1.55 . . . . 0.0 107.397 169.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -99.26 107.54 45.21 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.8 123.73 11.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.103 1.869 . . . . 0.0 110.409 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -77.08 -54.2 6.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.804 0.842 . . . . 0.0 109.979 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.011 0 O-C-N 122.337 -0.227 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 120.3 0.095 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -147.79 159.44 43.83 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.668 1.187 . . . . 0.0 110.29 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -113.25 74.57 0.87 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.945 1.298 . . . . 0.0 108.385 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.1 m -103.83 86.02 2.52 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.077 1.351 . . . . 0.0 109.473 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -140.52 167.78 21.35 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.606 1.562 . . . . 0.0 110.004 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -92.7 106.55 18.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.13 159.05 10.17 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.8 -39.94 1.31 Allowed 'Cis proline' 0 N--CA 1.456 -0.678 0 CA-C-N 118.674 1.237 . . . . 0.0 111.842 2.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.9 tp -105.86 -46.33 4.15 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.615 1.166 . . . . 0.0 110.42 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.4 p -122.02 -178.65 3.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.058 1.343 . . . . 0.0 110.286 -174.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -66.79 131.09 45.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.155 0.582 . . . . 0.0 110.194 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.9 t -132.24 119.16 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.9 t -140.99 129.34 22.38 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.402 1.081 . . . . 0.0 110.274 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -130.25 82.0 66.92 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.522 1.529 . . . . 0.0 107.13 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -81.83 66.35 8.45 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.643 2.896 . . . . 0.0 111.27 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 53.61 55.59 8.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.19 1.396 . . . . 0.0 111.286 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.055 0 O-C-N 122.133 -0.354 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 121.108 0.48 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -67.0 121.6 15.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.921 0.888 . . . . 0.0 110.43 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.5 t -99.11 78.18 2.23 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 92.9 m -99.83 84.97 2.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.037 1.335 . . . . 0.0 108.628 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -140.28 164.65 29.5 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.032 1.333 . . . . 0.0 110.556 -170.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -89.05 87.08 7.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.31 174.11 41.63 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.36 -41.27 0.47 Allowed 'Cis proline' 0 N--CA 1.46 -0.462 0 CA-C-N 119.312 1.556 . . . . 0.0 113.593 1.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.6 tp -113.14 -59.19 2.05 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.619 1.168 . . . . 0.0 109.572 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.7 p -99.73 179.81 4.42 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.945 1.298 . . . . 0.0 110.097 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -66.74 131.33 45.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.7 0.4 . . . . 0.0 110.498 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.5 t -133.15 118.89 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.7 t -141.03 116.42 10.08 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.988 1.315 . . . . 0.0 108.797 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -140.53 152.23 65.8 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.415 1.086 . . . . 0.0 109.335 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.52 62.97 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.345 2.697 . . . . 0.0 110.812 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -81.02 72.37 8.05 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.015 0.926 . . . . 0.0 110.254 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.091 0 O-C-N 121.98 -0.45 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 119.89 -0.1 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -70.14 81.02 0.51 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.838 1.255 . . . . 0.0 109.94 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 p -98.89 92.01 5.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.272 1.029 . . . . 0.0 108.498 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.0 m -99.12 119.33 37.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.018 0.927 . . . . 0.0 108.518 -175.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -140.31 175.14 9.84 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.73 1.212 . . . . 0.0 110.359 -170.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -105.98 113.27 26.71 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.31 1.044 . . . . 0.0 108.868 170.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.59 141.0 4.78 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.48 -44.26 0.58 Allowed 'Cis proline' 0 N--CA 1.458 -0.617 0 CA-C-N 119.58 1.69 . . . . 0.0 111.189 -1.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 tp -140.17 26.54 2.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.302 1.041 . . . . 0.0 109.709 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.6 p -140.78 154.28 46.2 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.532 1.533 . . . . 0.0 108.29 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -74.19 127.92 34.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -136.58 135.04 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.499 1.12 . . . . 0.0 108.908 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.9 t -140.62 161.84 36.8 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.624 1.17 . . . . 0.0 109.015 170.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.13 148.8 56.01 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.279 1.031 . . . . 0.0 109.943 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.73 67.35 7.89 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.708 2.939 . . . . 0.0 111.062 -173.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 72.62 -60.4 0.53 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.237 1.815 . . . . 0.0 112.881 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.099 0 O-C-N 121.772 -0.58 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 74.2 p . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -76.9 45.86 0.44 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.638 0.775 . . . . 0.0 111.133 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.6 t -99.76 81.92 2.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.1 m -98.68 72.48 2.0 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -100.02 145.9 27.36 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.184 1.393 . . . . 0.0 110.075 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -85.76 76.14 9.97 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.485 0.714 . . . . 0.0 109.429 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.29 152.56 21.75 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.38 -13.82 24.35 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 118.983 1.391 . . . . 0.0 112.752 2.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.3 tp -140.08 -54.87 0.54 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.237 1.015 . . . . 0.0 109.517 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.8 p -99.58 175.87 5.68 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.571 1.148 . . . . 0.0 110.768 -173.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -71.54 100.61 2.29 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.578 0.751 . . . . 0.0 109.148 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.8 t -99.73 114.03 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 t -140.74 159.46 42.15 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.377 1.071 . . . . 0.0 109.847 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -140.36 79.41 21.01 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.13 107.87 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.166 3.244 . . . . 0.0 113.123 -175.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -75.25 172.9 11.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.362 1.065 . . . . 0.0 111.122 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.087 0 O-C-N 122.001 -0.437 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 120.737 0.303 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -145.29 21.14 1.55 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.675 1.19 . . . . 0.0 110.623 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 p -99.63 -58.7 1.87 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.332 1.453 . . . . 0.0 107.205 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.0 m -138.26 109.97 7.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.855 2.062 . . . . 0.0 106.273 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -140.61 164.18 30.85 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.314 1.046 . . . . 0.0 110.503 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -79.23 84.99 5.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.09 176.5 39.18 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -58.91 -50.94 0.14 OUTLIER 'Cis proline' 0 CA--C 1.532 0.403 0 CA-C-N 119.037 1.419 . . . . 0.0 114.504 4.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 tp -103.06 -64.73 1.05 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.233 1.013 . . . . 0.0 109.295 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.2 p -99.58 -179.87 4.33 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.848 1.259 . . . . 0.0 108.244 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -68.13 123.58 21.07 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.017 -0.427 . . . . 0.0 110.629 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.3 t -139.06 148.22 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.4 m -99.55 75.99 1.98 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.904 0.881 . . . . 0.0 109.438 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -140.36 161.52 54.61 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 125.664 1.586 . . . . 0.0 108.849 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.45 75.47 1.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.759 2.973 . . . . 0.0 109.445 170.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 55.68 48.64 18.02 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.36 1.464 . . . . 0.0 110.882 -174.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.107 0 CA-C-N 115.873 -0.603 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 CA--C 1.524 -0.037 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -140.94 164.05 31.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.038 1.735 . . . . 0.0 110.041 -170.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -85.01 113.52 21.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.28 156.35 7.36 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.23 -46.32 0.37 Allowed 'Cis proline' 0 N--CA 1.458 -0.591 0 CA-C-N 118.769 1.285 . . . . 0.0 111.991 4.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.6 tp -99.96 -60.23 1.57 Allowed 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.37 1.068 . . . . 0.0 108.96 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 63.9 p -99.69 -174.59 2.75 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.95 1.3 . . . . 0.0 109.017 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -73.06 144.64 47.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 169.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.1 t -131.45 133.75 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.343 0.301 0 C-N-CA 124.418 1.087 . . . . 0.0 110.646 -176.539 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.3 m . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -140.34 152.65 45.98 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.216 1.406 . . . . 0.0 110.099 -170.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -86.96 80.87 8.29 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.46 171.15 43.42 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.97 -34.61 1.14 Allowed 'Cis proline' 0 N--CA 1.46 -0.482 0 CA-C-N 119.495 1.648 . . . . 0.0 113.515 -0.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.2 tp -121.72 -55.17 1.92 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.719 1.208 . . . . 0.0 109.889 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.5 p -99.56 176.75 5.38 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.548 1.139 . . . . 0.0 111.026 -170.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -70.31 101.58 1.95 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.543 0.737 . . . . 0.0 109.87 173.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.4 t -99.82 106.67 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 125.397 1.479 . . . . 0.0 108.545 175.008 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.456 -0.16 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -140.3 141.49 35.76 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.748 1.219 . . . . 0.0 110.157 -169.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -84.96 77.0 10.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.42 165.6 38.99 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -62.19 -34.74 1.51 Allowed 'Cis proline' 0 C--N 1.346 0.414 0 CA-C-N 119.688 1.744 . . . . 0.0 113.729 1.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.1 tp -123.72 -55.96 1.7 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.709 1.204 . . . . 0.0 109.389 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.6 p -99.38 178.76 4.79 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.704 1.202 . . . . 0.0 110.193 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -65.24 121.68 15.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.655 0.382 . . . . 0.0 110.252 172.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.75 149.51 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.454 -0.254 0 C-N-CA 122.413 0.285 . . . . 0.0 111.031 -177.194 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 96.2 m . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -140.55 169.69 17.18 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.214 1.406 . . . . 0.0 110.206 -172.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -92.73 118.56 31.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.82 152.2 6.22 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.49 -45.92 0.39 Allowed 'Cis proline' 0 N--CA 1.457 -0.674 0 CA-C-N 118.888 1.344 . . . . 0.0 111.249 -0.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.6 tp -104.83 -42.22 5.42 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.202 1.401 . . . . 0.0 110.214 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.1 p -116.53 -179.83 3.79 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.18 1.392 . . . . 0.0 109.827 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -75.5 136.36 40.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -138.61 136.59 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.103 0.961 . . . . 0.0 109.297 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 N--CA 1.455 -0.207 0 C-N-CA 125.112 1.365 . . . . 0.0 108.651 169.948 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -140.42 144.47 36.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.706 1.202 . . . . 0.0 110.152 -170.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -85.82 66.37 9.59 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.53 153.58 25.33 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.79 -18.57 17.12 Favored 'Cis proline' 0 N--CA 1.458 -0.562 0 CA-C-N 119.186 1.493 . . . . 0.0 112.517 1.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.3 tp -139.97 -52.66 0.52 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.639 1.176 . . . . 0.0 109.226 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 p -99.35 177.0 5.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.7 1.2 . . . . 0.0 110.023 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -68.95 115.8 8.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.977 0.511 . . . . 0.0 110.267 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.66 146.25 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.453 -0.298 0 C-N-CA 122.434 0.293 . . . . 0.0 111.0 -177.147 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -140.46 167.62 21.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.714 1.206 . . . . 0.0 110.197 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -84.28 100.71 11.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 169.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.77 164.23 15.34 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.05 -47.84 0.29 Allowed 'Cis proline' 0 N--CA 1.46 -0.474 0 CA-C-N 119.14 1.47 . . . . 0.0 112.965 3.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tt -104.02 -59.69 1.69 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.583 1.153 . . . . 0.0 108.357 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.8 p -99.37 -176.64 3.35 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.88 1.272 . . . . 0.0 109.088 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -71.9 132.57 44.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.26 149.54 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.703 0.801 . . . . 0.0 109.243 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 N--CA 1.455 -0.188 0 C-N-CA 125.415 1.486 . . . . 0.0 108.689 171.82 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.457 -0.078 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -140.3 161.5 37.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.037 1.335 . . . . 0.0 110.202 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -98.29 98.74 9.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.15 143.42 8.46 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.57 -46.12 0.31 Allowed 'Cis proline' 0 C--N 1.347 0.459 0 CA-C-N 119.691 1.745 . . . . 0.0 111.607 -5.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 tp -140.46 36.08 1.85 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.273 1.029 . . . . 0.0 108.765 169.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -140.74 139.44 34.66 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.996 1.318 . . . . 0.0 109.257 -171.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -73.58 98.59 2.86 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.1 t -99.63 103.06 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.339 0.127 0 C-N-CA 125.178 1.391 . . . . 0.0 108.622 179.018 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -140.38 166.38 24.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.807 1.643 . . . . 0.0 109.899 -173.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -91.84 106.62 18.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.37 161.91 12.26 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.0 -40.34 1.23 Allowed 'Cis proline' 0 N--CA 1.456 -0.721 0 CA-C-N 118.727 1.264 . . . . 0.0 111.755 2.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.7 tp -104.17 -56.43 2.19 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.533 1.133 . . . . 0.0 109.682 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.2 p -107.31 -176.5 3.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.067 1.347 . . . . 0.0 110.236 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -67.18 139.41 57.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.8 t -138.64 126.54 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 t . . . . . 0 C--N 1.341 0.231 0 C-N-CA 124.716 1.207 . . . . 0.0 109.132 176.617 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 98.3 m . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -140.95 165.07 28.55 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.21 1.004 . . . . 0.0 111.526 -170.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -90.82 119.23 30.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.46 156.37 7.39 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.34 -44.64 0.48 Allowed 'Cis proline' 0 N--CA 1.456 -0.705 0 CA-C-N 118.682 1.241 . . . . 0.0 111.56 1.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tt -104.34 -55.97 2.27 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.964 1.306 . . . . 0.0 108.258 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.0 p -99.58 -176.56 3.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.068 1.347 . . . . 0.0 109.504 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -76.74 138.18 39.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 171.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.8 t -137.93 147.17 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.452 -0.334 0 C-N-CA 122.916 0.486 . . . . 0.0 110.678 174.885 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -125.19 138.23 54.13 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.741 1.216 . . . . 0.0 108.998 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -82.9 70.11 9.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.197 0.599 . . . . 0.0 109.893 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.96 148.43 16.91 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.97 -16.37 21.19 Favored 'Cis proline' 0 N--CA 1.459 -0.545 0 CA-C-N 119.32 1.56 . . . . 0.0 112.751 3.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 tp -140.05 -54.63 0.54 Allowed 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.236 1.014 . . . . 0.0 109.576 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.3 p -99.32 173.81 6.59 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.512 1.125 . . . . 0.0 110.615 -172.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -69.17 102.88 1.77 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.401 0.681 . . . . 0.0 109.63 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.52 118.26 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 125.103 1.361 . . . . 0.0 109.606 -175.534 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -140.08 139.59 35.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.856 1.262 . . . . 0.0 109.985 -169.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -85.04 60.5 6.29 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.452 0.701 . . . . 0.0 110.096 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.95 129.77 7.96 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.099 1.333 . . . . 0.0 109.983 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.65 -49.42 0.23 Allowed 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.941 1.871 . . . . 0.0 111.073 -0.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -140.9 33.58 1.77 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.103 0.961 . . . . 0.0 109.189 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.4 p -140.68 147.81 39.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.089 1.356 . . . . 0.0 108.506 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -72.9 93.15 1.68 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.755 0.422 . . . . 0.0 110.367 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.8 t -99.71 137.76 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.108 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -140.41 165.82 26.38 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.925 1.29 . . . . 0.0 110.576 -172.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -84.3 137.8 33.25 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.52 174.73 31.13 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.93 1.252 . . . . 0.0 110.808 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -60.87 -47.62 0.2 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.502 0 CA-C-N 118.822 1.311 . . . . 0.0 114.016 5.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 tt -102.18 -64.84 1.03 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.1 0.96 . . . . 0.0 108.85 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.6 p -99.56 -175.67 3.06 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.802 1.241 . . . . 0.0 109.212 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -69.6 139.28 53.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.3 t -140.04 145.04 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.311 1.044 . . . . 0.0 108.754 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m . . . . . 0 C--N 1.339 0.148 0 C-N-CA 124.393 1.077 . . . . 0.0 110.842 175.297 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -140.31 172.82 12.2 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.241 1.417 . . . . 0.0 110.405 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -103.26 114.96 29.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.91 0.884 . . . . 0.0 108.779 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.49 140.31 3.49 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.73 -45.06 0.48 Allowed 'Cis proline' 0 N--CA 1.458 -0.575 0 CA-C-N 119.712 1.756 . . . . 0.0 111.457 1.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.0 tp -140.22 25.41 2.26 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.212 1.005 . . . . 0.0 109.842 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.8 p -140.62 159.85 41.3 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.409 1.483 . . . . 0.0 108.319 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -76.93 125.76 29.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.76 147.54 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.679 1.191 . . . . 0.0 108.461 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 CA--C 1.53 0.195 0 C-N-CA 124.055 0.942 . . . . 0.0 109.456 175.61 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.7 m . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -140.73 163.76 32.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.116 1.366 . . . . 0.0 110.612 -170.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -89.12 116.44 27.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.9 156.8 7.3 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.14 -44.71 0.48 Allowed 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 118.647 1.223 . . . . 0.0 111.772 3.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.0 tp -102.03 -58.12 1.94 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.591 1.157 . . . . 0.0 109.113 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.4 p -99.88 -176.32 3.22 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.893 1.277 . . . . 0.0 109.543 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -74.81 139.31 43.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.21 152.51 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.273 1.029 . . . . 0.0 108.553 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 90.3 m . . . . . 0 C--N 1.34 0.171 0 C-N-CA 124.361 1.064 . . . . 0.0 110.213 172.829 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.2 m . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -140.48 162.48 35.24 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.015 1.326 . . . . 0.0 110.065 -172.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -85.65 111.18 19.85 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.7 155.19 7.08 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.18 -43.14 0.64 Allowed 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 118.726 1.263 . . . . 0.0 112.02 4.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tt -105.42 -58.32 1.91 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.629 1.171 . . . . 0.0 108.221 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.0 p -99.56 -178.76 3.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.038 1.335 . . . . 0.0 109.528 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -74.38 139.84 44.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 72.8 t -136.19 130.25 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.975 0.91 . . . . 0.0 109.317 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.455 -0.177 0 C-N-CA 125.576 1.55 . . . . 0.0 107.397 169.343 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.1 m . . . . . 0 C--O 1.23 0.077 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -140.52 167.78 21.35 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.606 1.562 . . . . 0.0 110.004 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -92.7 106.55 18.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.13 159.05 10.17 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.8 -39.94 1.31 Allowed 'Cis proline' 0 N--CA 1.456 -0.678 0 CA-C-N 118.674 1.237 . . . . 0.0 111.842 2.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.9 tp -105.86 -46.33 4.15 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.615 1.166 . . . . 0.0 110.42 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.4 p -122.02 -178.65 3.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.058 1.343 . . . . 0.0 110.286 -174.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -66.79 131.09 45.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.155 0.582 . . . . 0.0 110.194 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.9 t -132.24 119.16 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.9 t . . . . . 0 C--N 1.342 0.248 0 C-N-CA 124.402 1.081 . . . . 0.0 110.274 177.508 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 92.9 m . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -140.28 164.65 29.5 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.032 1.333 . . . . 0.0 110.556 -170.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -89.05 87.08 7.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.31 174.11 41.63 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.36 -41.27 0.47 Allowed 'Cis proline' 0 N--CA 1.46 -0.462 0 CA-C-N 119.312 1.556 . . . . 0.0 113.593 1.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.6 tp -113.14 -59.19 2.05 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.619 1.168 . . . . 0.0 109.572 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.7 p -99.73 179.81 4.42 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.945 1.298 . . . . 0.0 110.097 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -66.74 131.33 45.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.7 0.4 . . . . 0.0 110.498 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.5 t -133.15 118.89 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 C--N 1.34 0.174 0 C-N-CA 124.988 1.315 . . . . 0.0 108.797 173.906 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -140.31 175.14 9.84 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.73 1.212 . . . . 0.0 110.359 -170.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -105.98 113.27 26.71 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.31 1.044 . . . . 0.0 108.868 170.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.59 141.0 4.78 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.48 -44.26 0.58 Allowed 'Cis proline' 0 N--CA 1.458 -0.617 0 CA-C-N 119.58 1.69 . . . . 0.0 111.189 -1.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 tp -140.17 26.54 2.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.302 1.041 . . . . 0.0 109.709 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.6 p -140.78 154.28 46.2 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.532 1.533 . . . . 0.0 108.29 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -74.19 127.92 34.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -136.58 135.04 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.499 1.12 . . . . 0.0 108.908 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.455 -0.199 0 C-N-CA 124.624 1.17 . . . . 0.0 109.015 170.496 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.1 m . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -100.02 145.9 27.36 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.184 1.393 . . . . 0.0 110.075 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -85.76 76.14 9.97 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.485 0.714 . . . . 0.0 109.429 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.29 152.56 21.75 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.38 -13.82 24.35 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 118.983 1.391 . . . . 0.0 112.752 2.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.3 tp -140.08 -54.87 0.54 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.237 1.015 . . . . 0.0 109.517 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.8 p -99.58 175.87 5.68 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.571 1.148 . . . . 0.0 110.768 -173.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -71.54 100.61 2.29 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.578 0.751 . . . . 0.0 109.148 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.8 t -99.73 114.03 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.34 0.156 0 C-N-CA 124.377 1.071 . . . . 0.0 109.847 174.776 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.0 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -140.61 164.18 30.85 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.314 1.046 . . . . 0.0 110.503 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -79.23 84.99 5.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.09 176.5 39.18 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -58.91 -50.94 0.14 OUTLIER 'Cis proline' 0 CA--C 1.532 0.403 0 CA-C-N 119.037 1.419 . . . . 0.0 114.504 4.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 tp -103.06 -64.73 1.05 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.233 1.013 . . . . 0.0 109.295 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.2 p -99.58 -179.87 4.33 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.848 1.259 . . . . 0.0 108.244 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -68.13 123.58 21.07 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.017 -0.427 . . . . 0.0 110.629 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.3 t -139.06 148.22 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.4 m . . . . . 0 N--CA 1.455 -0.193 0 C-N-CA 123.904 0.881 . . . . 0.0 109.438 176.049 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.9 p . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.451 0.167 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -74.04 159.27 32.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.886 0.874 . . . . 0.0 110.967 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.9 t -99.39 68.62 1.62 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m -111.63 91.35 3.63 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.856 1.663 . . . . 0.0 109.033 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -140.94 164.05 31.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.038 1.735 . . . . 0.0 110.041 -170.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -85.01 113.52 21.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.28 156.35 7.36 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.23 -46.32 0.37 Allowed 'Cis proline' 0 N--CA 1.458 -0.591 0 CA-C-N 118.769 1.285 . . . . 0.0 111.991 4.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.6 tp -99.96 -60.23 1.57 Allowed 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.37 1.068 . . . . 0.0 108.96 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 63.9 p -99.69 -174.59 2.75 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.95 1.3 . . . . 0.0 109.017 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -73.06 144.64 47.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 169.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.1 t -131.45 133.75 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.5 t -140.12 91.43 2.45 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.418 1.087 . . . . 0.0 110.646 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -99.85 119.21 60.27 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.558 1.143 . . . . 0.0 108.42 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.12 84.5 2.03 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.109 2.54 . . . . 0.0 110.15 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -63.05 -64.41 0.92 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.692 0.797 . . . . 0.0 111.086 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.084 0 O-C-N 122.103 -0.373 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.4 p . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 120.387 0.137 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -81.05 60.73 4.34 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.893 0.877 . . . . 0.0 109.885 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -99.94 -178.9 3.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.706 1.202 . . . . 0.0 109.31 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.3 m -109.79 86.3 2.27 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.464 1.505 . . . . 0.0 108.431 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -140.34 152.65 45.98 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.216 1.406 . . . . 0.0 110.099 -170.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -86.96 80.87 8.29 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.46 171.15 43.42 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.97 -34.61 1.14 Allowed 'Cis proline' 0 N--CA 1.46 -0.482 0 CA-C-N 119.495 1.648 . . . . 0.0 113.515 -0.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.2 tp -121.72 -55.17 1.92 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.719 1.208 . . . . 0.0 109.889 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.5 p -99.56 176.75 5.38 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.548 1.139 . . . . 0.0 111.026 -170.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -70.31 101.58 1.95 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.543 0.737 . . . . 0.0 109.87 173.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.4 t -99.82 106.67 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t -140.18 71.61 1.38 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.397 1.479 . . . . 0.0 108.545 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -125.31 74.41 68.02 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 125.014 1.325 . . . . 0.0 108.177 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.53 109.49 2.28 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.012 2.475 . . . . 0.0 110.371 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -68.86 -50.73 47.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.88 0.872 . . . . 0.0 110.592 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.031 0 O-C-N 122.231 -0.293 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 111.174 0.064 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -66.21 152.0 45.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.435 0.694 . . . . 0.0 110.954 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -99.47 99.78 10.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.013 1.325 . . . . 0.0 108.502 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.6 m -99.83 132.16 45.35 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.149 0.98 . . . . 0.0 109.49 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -140.3 141.49 35.76 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.748 1.219 . . . . 0.0 110.157 -169.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -84.96 77.0 10.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.42 165.6 38.99 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -62.19 -34.74 1.51 Allowed 'Cis proline' 0 C--N 1.346 0.414 0 CA-C-N 119.688 1.744 . . . . 0.0 113.729 1.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.1 tp -123.72 -55.96 1.7 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.709 1.204 . . . . 0.0 109.389 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.6 p -99.38 178.76 4.79 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.704 1.202 . . . . 0.0 110.193 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -65.24 121.68 15.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.655 0.382 . . . . 0.0 110.252 172.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.75 149.51 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.4 t -140.16 144.69 36.78 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.413 0.285 . . . . 0.0 111.031 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -140.24 170.93 8.6 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.591 1.556 . . . . 0.0 108.975 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.79 167.11 2.39 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.33 2.687 . . . . 0.0 113.698 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -54.35 -55.63 26.58 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.398 1.079 . . . . 0.0 111.554 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.056 0 O-C-N 122.313 -0.242 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.9 p . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 119.854 -0.117 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -72.29 87.68 1.14 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.116 0.966 . . . . 0.0 109.322 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.5 m -99.55 99.39 10.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.782 1.233 . . . . 0.0 108.876 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 96.2 m -99.07 114.23 26.83 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.247 1.419 . . . . 0.0 109.099 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -140.55 169.69 17.18 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.214 1.406 . . . . 0.0 110.206 -172.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -92.73 118.56 31.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.82 152.2 6.22 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.49 -45.92 0.39 Allowed 'Cis proline' 0 N--CA 1.457 -0.674 0 CA-C-N 118.888 1.344 . . . . 0.0 111.249 -0.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.6 tp -104.83 -42.22 5.42 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.202 1.401 . . . . 0.0 110.214 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.1 p -116.53 -179.83 3.79 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.18 1.392 . . . . 0.0 109.827 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -75.5 136.36 40.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -138.61 136.59 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.103 0.961 . . . . 0.0 109.297 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.0 m -108.81 122.56 47.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.112 1.365 . . . . 0.0 108.651 169.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -99.71 109.16 54.58 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -67.81 -52.75 0.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.134 2.556 . . . . 0.0 111.494 -170.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 65.83 -73.31 0.07 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.543 1.937 . . . . 0.0 112.995 170.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.093 0 O-C-N 121.885 -0.51 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 120.005 -0.045 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -80.63 75.24 7.53 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.946 0.898 . . . . 0.0 108.875 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 p -99.44 100.05 11.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.843 1.257 . . . . 0.0 109.078 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.3 m -99.73 129.07 45.82 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.649 1.18 . . . . 0.0 109.232 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -140.42 144.47 36.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.706 1.202 . . . . 0.0 110.152 -170.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -85.82 66.37 9.59 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.53 153.58 25.33 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.79 -18.57 17.12 Favored 'Cis proline' 0 N--CA 1.458 -0.562 0 CA-C-N 119.186 1.493 . . . . 0.0 112.517 1.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.3 tp -139.97 -52.66 0.52 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.639 1.176 . . . . 0.0 109.226 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 p -99.35 177.0 5.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.7 1.2 . . . . 0.0 110.023 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -68.95 115.8 8.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.977 0.511 . . . . 0.0 110.267 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.66 146.25 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.0 t -140.1 137.85 34.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.434 0.293 . . . . 0.0 111.0 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -102.93 109.5 61.48 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.51 -53.84 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.621 2.214 . . . . 0.0 111.159 -173.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 67.4 -67.62 0.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.617 1.967 . . . . 0.0 112.605 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.093 0 O-C-N 121.781 -0.574 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 110.864 -0.05 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -54.56 147.44 14.23 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.223 1.009 . . . . 0.0 111.847 -174.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.3 p -99.37 98.05 9.03 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.283 1.433 . . . . 0.0 108.259 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.1 m -99.21 113.9 26.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.504 1.522 . . . . 0.0 109.013 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -140.46 167.62 21.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.714 1.206 . . . . 0.0 110.197 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -84.28 100.71 11.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 169.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.77 164.23 15.34 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.05 -47.84 0.29 Allowed 'Cis proline' 0 N--CA 1.46 -0.474 0 CA-C-N 119.14 1.47 . . . . 0.0 112.965 3.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tt -104.02 -59.69 1.69 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.583 1.153 . . . . 0.0 108.357 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.8 p -99.37 -176.64 3.35 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.88 1.272 . . . . 0.0 109.088 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -71.9 132.57 44.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.26 149.54 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.703 0.801 . . . . 0.0 109.243 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.4 m -110.36 118.04 35.23 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.415 1.486 . . . . 0.0 108.689 171.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -99.67 146.43 31.82 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 109.245 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.0 133.76 37.05 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.256 2.637 . . . . 0.0 110.509 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.6 134.39 11.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.05 0 O-C-N 122.135 -0.353 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.61 0.243 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -82.27 47.81 1.19 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.912 0.885 . . . . 0.0 109.923 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 m -141.08 165.76 26.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.155 1.382 . . . . 0.0 109.46 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.3 m -107.1 92.33 4.03 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.961 1.304 . . . . 0.0 109.303 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -140.3 161.5 37.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.037 1.335 . . . . 0.0 110.202 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -98.29 98.74 9.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.15 143.42 8.46 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.57 -46.12 0.31 Allowed 'Cis proline' 0 C--N 1.347 0.459 0 CA-C-N 119.691 1.745 . . . . 0.0 111.607 -5.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 tp -140.46 36.08 1.85 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.273 1.029 . . . . 0.0 108.765 169.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -140.74 139.44 34.66 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.996 1.318 . . . . 0.0 109.257 -171.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -73.58 98.59 2.86 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.1 t -99.63 103.06 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -140.4 61.88 1.51 Allowed 'General case' 0 C--N 1.339 0.127 0 C-N-CA 125.178 1.391 . . . . 0.0 108.622 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -140.27 148.06 52.56 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.071 1.348 . . . . 0.0 108.465 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.03 72.25 6.61 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.555 2.837 . . . . 0.0 110.011 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.39 -21.98 2.52 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.603 1.161 . . . . 0.0 112.172 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.044 0 O-C-N 121.654 -0.654 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 57.1 m . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 120.232 0.063 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -66.11 162.24 20.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.181 0.992 . . . . 0.0 110.531 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 t -98.81 67.92 1.72 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m -99.92 84.74 2.93 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.675 1.59 . . . . 0.0 109.423 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -140.38 166.38 24.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.807 1.643 . . . . 0.0 109.899 -173.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -91.84 106.62 18.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.37 161.91 12.26 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.0 -40.34 1.23 Allowed 'Cis proline' 0 N--CA 1.456 -0.721 0 CA-C-N 118.727 1.264 . . . . 0.0 111.755 2.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.7 tp -104.17 -56.43 2.19 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.533 1.133 . . . . 0.0 109.682 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.2 p -107.31 -176.5 3.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.067 1.347 . . . . 0.0 110.236 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -67.18 139.41 57.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.8 t -138.64 126.54 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 t -140.66 100.45 3.86 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.716 1.207 . . . . 0.0 109.132 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -140.33 162.83 47.57 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 125.698 1.599 . . . . 0.0 109.596 -170.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.53 154.42 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.631 2.887 . . . . 0.0 112.889 170.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.59 -52.68 64.44 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.838 0.855 . . . . 0.0 111.239 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.086 0 O-C-N 122.327 -0.233 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.709 -0.108 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -84.41 74.74 10.32 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.028 0.931 . . . . 0.0 108.817 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.8 p -99.42 98.25 9.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.939 0.895 . . . . 0.0 110.081 -169.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.85 117.85 35.03 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.851 1.26 . . . . 0.0 108.382 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -140.95 165.07 28.55 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.21 1.004 . . . . 0.0 111.526 -170.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -90.82 119.23 30.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.46 156.37 7.39 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.34 -44.64 0.48 Allowed 'Cis proline' 0 N--CA 1.456 -0.705 0 CA-C-N 118.682 1.241 . . . . 0.0 111.56 1.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tt -104.34 -55.97 2.27 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.964 1.306 . . . . 0.0 108.258 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.0 p -99.58 -176.56 3.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.068 1.347 . . . . 0.0 109.504 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -76.74 138.18 39.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 171.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.8 t -137.93 147.17 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.44 145.02 44.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.916 0.486 . . . . 0.0 110.678 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.27 86.24 17.2 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -81.71 65.05 8.62 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.442 2.761 . . . . 0.0 110.171 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -107.72 150.07 27.39 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.583 1.153 . . . . 0.0 110.296 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.088 0 O-C-N 122.208 -0.308 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 N--CA 1.474 0.772 0 CA-C-O 120.355 0.122 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -74.93 72.17 2.09 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.499 1.12 . . . . 0.0 109.107 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m -140.38 -163.64 1.56 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.746 1.619 . . . . 0.0 109.109 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.2 m -101.96 149.98 23.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.621 0.768 . . . . 0.0 109.706 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -125.19 138.23 54.13 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.741 1.216 . . . . 0.0 108.998 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -82.9 70.11 9.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.197 0.599 . . . . 0.0 109.893 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.96 148.43 16.91 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.97 -16.37 21.19 Favored 'Cis proline' 0 N--CA 1.459 -0.545 0 CA-C-N 119.32 1.56 . . . . 0.0 112.751 3.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 tp -140.05 -54.63 0.54 Allowed 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.236 1.014 . . . . 0.0 109.576 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.3 p -99.32 173.81 6.59 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.512 1.125 . . . . 0.0 110.615 -172.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -69.17 102.88 1.77 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.401 0.681 . . . . 0.0 109.63 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.52 118.26 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.2 m -99.83 109.81 22.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.103 1.361 . . . . 0.0 109.606 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -140.03 154.65 70.6 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.979 1.312 . . . . 0.0 109.076 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.53 77.48 3.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.506 2.804 . . . . 0.0 109.959 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -68.57 -58.25 4.55 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.453 0.701 . . . . 0.0 109.823 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.06 0 CA-C-N 116.672 -0.24 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 120.282 0.087 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -79.77 72.93 6.51 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.724 1.21 . . . . 0.0 109.409 -176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.0 m -99.83 -178.84 3.99 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.624 1.17 . . . . 0.0 110.189 -175.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m -99.32 132.57 44.55 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -140.08 139.59 35.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.856 1.262 . . . . 0.0 109.985 -169.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -85.04 60.5 6.29 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.452 0.701 . . . . 0.0 110.096 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.95 129.77 7.96 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.099 1.333 . . . . 0.0 109.983 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.65 -49.42 0.23 Allowed 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.941 1.871 . . . . 0.0 111.073 -0.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -140.9 33.58 1.77 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.103 0.961 . . . . 0.0 109.189 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.4 p -140.68 147.81 39.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.089 1.356 . . . . 0.0 108.506 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -72.9 93.15 1.68 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.755 0.422 . . . . 0.0 110.367 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.8 t -99.71 137.76 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.6 t -140.06 72.45 1.4 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -124.02 162.69 39.98 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.084 1.754 . . . . 0.0 108.397 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -49.98 110.02 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.795 2.997 . . . . 0.0 113.217 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -78.75 -58.86 3.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.913 0.885 . . . . 0.0 110.202 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.055 0 O-C-N 122.214 -0.304 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 47.4 p . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 120.254 0.073 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -155.28 175.17 14.21 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.56 1.144 . . . . 0.0 109.861 177.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 t -140.16 171.46 14.15 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.349 1.06 . . . . 0.0 109.526 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.0 m -140.1 155.37 47.04 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.246 1.019 . . . . 0.0 109.971 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -140.41 165.82 26.38 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.925 1.29 . . . . 0.0 110.576 -172.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -84.3 137.8 33.25 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.52 174.73 31.13 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.93 1.252 . . . . 0.0 110.808 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -60.87 -47.62 0.2 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.502 0 CA-C-N 118.822 1.311 . . . . 0.0 114.016 5.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 tt -102.18 -64.84 1.03 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.1 0.96 . . . . 0.0 108.85 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.6 p -99.56 -175.67 3.06 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.802 1.241 . . . . 0.0 109.212 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -69.6 139.28 53.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.3 t -140.04 145.04 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.311 1.044 . . . . 0.0 108.754 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -101.61 150.94 22.58 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.393 1.077 . . . . 0.0 110.842 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -118.92 75.76 13.96 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.142 1.377 . . . . 0.0 108.89 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.35 107.92 1.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.309 2.673 . . . . 0.0 110.295 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -69.92 -52.83 21.34 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.809 0.844 . . . . 0.0 110.364 -177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.03 0 O-C-N 122.285 -0.259 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -179.07 176.38 0.89 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 125.53 1.532 . . . . 0.0 109.573 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.1 t -138.83 116.82 11.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.6 m -99.44 124.33 44.49 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -140.31 172.82 12.2 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.241 1.417 . . . . 0.0 110.405 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -103.26 114.96 29.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.91 0.884 . . . . 0.0 108.779 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.49 140.31 3.49 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.73 -45.06 0.48 Allowed 'Cis proline' 0 N--CA 1.458 -0.575 0 CA-C-N 119.712 1.756 . . . . 0.0 111.457 1.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.0 tp -140.22 25.41 2.26 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.212 1.005 . . . . 0.0 109.842 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.8 p -140.62 159.85 41.3 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.409 1.483 . . . . 0.0 108.319 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -76.93 125.76 29.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.76 147.54 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.679 1.191 . . . . 0.0 108.461 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.3 t -140.44 161.29 38.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.055 0.942 . . . . 0.0 109.456 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -129.46 77.69 76.9 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.053 0.941 . . . . 0.0 112.29 -169.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -47.19 120.98 4.75 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.227 3.285 . . . . 0.0 111.928 170.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -153.07 168.86 24.5 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.737 0.815 . . . . 0.0 110.578 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.087 0 O-C-N 122.128 -0.357 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.29 0.091 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -112.97 85.46 2.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.299 1.44 . . . . 0.0 107.793 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.2 t -98.96 95.15 6.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -170.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.7 m -99.32 116.99 32.77 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.5 1.52 . . . . 0.0 108.672 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -140.73 163.76 32.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.116 1.366 . . . . 0.0 110.612 -170.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -89.12 116.44 27.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.9 156.8 7.3 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.14 -44.71 0.48 Allowed 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 118.647 1.223 . . . . 0.0 111.772 3.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.0 tp -102.03 -58.12 1.94 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.591 1.157 . . . . 0.0 109.113 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.4 p -99.88 -176.32 3.22 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.893 1.277 . . . . 0.0 109.543 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -74.81 139.31 43.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.21 152.51 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.273 1.029 . . . . 0.0 108.553 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 90.3 m -122.71 151.51 41.48 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.361 1.064 . . . . 0.0 110.213 172.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -125.6 89.65 52.07 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.165 1.386 . . . . 0.0 108.65 172.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -64.24 175.69 3.12 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.076 3.184 . . . . 0.0 112.587 172.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -77.57 71.42 4.06 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 170.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.077 0 O-C-N 122.145 -0.347 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 111.369 0.137 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -98.34 168.05 10.46 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.142 0.977 . . . . 0.0 109.98 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -99.39 87.78 3.71 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.2 m -98.93 105.3 17.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.313 1.445 . . . . 0.0 107.924 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -140.48 162.48 35.24 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.015 1.326 . . . . 0.0 110.065 -172.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -85.65 111.18 19.85 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.7 155.19 7.08 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.18 -43.14 0.64 Allowed 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 118.726 1.263 . . . . 0.0 112.02 4.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tt -105.42 -58.32 1.91 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.629 1.171 . . . . 0.0 108.221 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.0 p -99.56 -178.76 3.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.038 1.335 . . . . 0.0 109.528 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -74.38 139.84 44.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 72.8 t -136.19 130.25 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.975 0.91 . . . . 0.0 109.317 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.7 m -105.3 103.41 12.94 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.576 1.55 . . . . 0.0 107.397 169.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -99.26 107.54 45.21 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.8 123.73 11.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.103 1.869 . . . . 0.0 110.409 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -77.08 -54.2 6.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.804 0.842 . . . . 0.0 109.979 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.011 0 O-C-N 122.337 -0.227 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 120.3 0.095 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -147.79 159.44 43.83 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.668 1.187 . . . . 0.0 110.29 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -113.25 74.57 0.87 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.945 1.298 . . . . 0.0 108.385 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.1 m -103.83 86.02 2.52 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.077 1.351 . . . . 0.0 109.473 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -140.52 167.78 21.35 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.606 1.562 . . . . 0.0 110.004 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -92.7 106.55 18.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.13 159.05 10.17 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.8 -39.94 1.31 Allowed 'Cis proline' 0 N--CA 1.456 -0.678 0 CA-C-N 118.674 1.237 . . . . 0.0 111.842 2.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.9 tp -105.86 -46.33 4.15 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.615 1.166 . . . . 0.0 110.42 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.4 p -122.02 -178.65 3.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.058 1.343 . . . . 0.0 110.286 -174.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -66.79 131.09 45.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.155 0.582 . . . . 0.0 110.194 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.9 t -132.24 119.16 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.9 t -140.99 129.34 22.38 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.402 1.081 . . . . 0.0 110.274 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -130.25 82.0 66.92 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.522 1.529 . . . . 0.0 107.13 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -81.83 66.35 8.45 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.643 2.896 . . . . 0.0 111.27 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 53.61 55.59 8.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.19 1.396 . . . . 0.0 111.286 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.055 0 O-C-N 122.133 -0.354 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 121.108 0.48 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -67.0 121.6 15.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.921 0.888 . . . . 0.0 110.43 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.5 t -99.11 78.18 2.23 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 92.9 m -99.83 84.97 2.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.037 1.335 . . . . 0.0 108.628 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -140.28 164.65 29.5 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.032 1.333 . . . . 0.0 110.556 -170.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -89.05 87.08 7.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.31 174.11 41.63 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.36 -41.27 0.47 Allowed 'Cis proline' 0 N--CA 1.46 -0.462 0 CA-C-N 119.312 1.556 . . . . 0.0 113.593 1.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.6 tp -113.14 -59.19 2.05 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.619 1.168 . . . . 0.0 109.572 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.7 p -99.73 179.81 4.42 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.945 1.298 . . . . 0.0 110.097 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -66.74 131.33 45.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.7 0.4 . . . . 0.0 110.498 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.5 t -133.15 118.89 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.7 t -141.03 116.42 10.08 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.988 1.315 . . . . 0.0 108.797 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -140.53 152.23 65.8 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.415 1.086 . . . . 0.0 109.335 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.52 62.97 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.345 2.697 . . . . 0.0 110.812 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -81.02 72.37 8.05 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.015 0.926 . . . . 0.0 110.254 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.091 0 O-C-N 121.98 -0.45 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 119.89 -0.1 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -70.14 81.02 0.51 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.838 1.255 . . . . 0.0 109.94 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 p -98.89 92.01 5.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.272 1.029 . . . . 0.0 108.498 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.0 m -99.12 119.33 37.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.018 0.927 . . . . 0.0 108.518 -175.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -140.31 175.14 9.84 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.73 1.212 . . . . 0.0 110.359 -170.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -105.98 113.27 26.71 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.31 1.044 . . . . 0.0 108.868 170.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.59 141.0 4.78 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.48 -44.26 0.58 Allowed 'Cis proline' 0 N--CA 1.458 -0.617 0 CA-C-N 119.58 1.69 . . . . 0.0 111.189 -1.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 tp -140.17 26.54 2.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.302 1.041 . . . . 0.0 109.709 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.6 p -140.78 154.28 46.2 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.532 1.533 . . . . 0.0 108.29 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -74.19 127.92 34.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -136.58 135.04 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.499 1.12 . . . . 0.0 108.908 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.9 t -140.62 161.84 36.8 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.624 1.17 . . . . 0.0 109.015 170.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.13 148.8 56.01 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.279 1.031 . . . . 0.0 109.943 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.73 67.35 7.89 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.708 2.939 . . . . 0.0 111.062 -173.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 72.62 -60.4 0.53 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.237 1.815 . . . . 0.0 112.881 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.099 0 O-C-N 121.772 -0.58 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 74.2 p . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -76.9 45.86 0.44 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.638 0.775 . . . . 0.0 111.133 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.6 t -99.76 81.92 2.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.1 m -98.68 72.48 2.0 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -100.02 145.9 27.36 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.184 1.393 . . . . 0.0 110.075 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -85.76 76.14 9.97 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.485 0.714 . . . . 0.0 109.429 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.29 152.56 21.75 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.38 -13.82 24.35 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 118.983 1.391 . . . . 0.0 112.752 2.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.3 tp -140.08 -54.87 0.54 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.237 1.015 . . . . 0.0 109.517 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.8 p -99.58 175.87 5.68 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.571 1.148 . . . . 0.0 110.768 -173.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -71.54 100.61 2.29 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.578 0.751 . . . . 0.0 109.148 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.8 t -99.73 114.03 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 t -140.74 159.46 42.15 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.377 1.071 . . . . 0.0 109.847 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -140.36 79.41 21.01 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.13 107.87 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.166 3.244 . . . . 0.0 113.123 -175.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -75.25 172.9 11.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.362 1.065 . . . . 0.0 111.122 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.087 0 O-C-N 122.001 -0.437 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 120.737 0.303 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -145.29 21.14 1.55 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.675 1.19 . . . . 0.0 110.623 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 p -99.63 -58.7 1.87 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.332 1.453 . . . . 0.0 107.205 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.0 m -138.26 109.97 7.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.855 2.062 . . . . 0.0 106.273 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -140.61 164.18 30.85 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.314 1.046 . . . . 0.0 110.503 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -79.23 84.99 5.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.09 176.5 39.18 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -58.91 -50.94 0.14 OUTLIER 'Cis proline' 0 CA--C 1.532 0.403 0 CA-C-N 119.037 1.419 . . . . 0.0 114.504 4.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 tp -103.06 -64.73 1.05 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.233 1.013 . . . . 0.0 109.295 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.2 p -99.58 -179.87 4.33 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.848 1.259 . . . . 0.0 108.244 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -68.13 123.58 21.07 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.017 -0.427 . . . . 0.0 110.629 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.3 t -139.06 148.22 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.4 m -99.55 75.99 1.98 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.904 0.881 . . . . 0.0 109.438 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -140.36 161.52 54.61 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 125.664 1.586 . . . . 0.0 108.849 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.45 75.47 1.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.759 2.973 . . . . 0.0 109.445 170.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 55.68 48.64 18.02 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.36 1.464 . . . . 0.0 110.882 -174.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.107 0 CA-C-N 115.873 -0.603 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 CA--C 1.524 -0.037 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -140.94 164.05 31.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.038 1.735 . . . . 0.0 110.041 -170.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -85.01 113.52 21.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.28 156.35 7.36 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.23 -46.32 0.37 Allowed 'Cis proline' 0 N--CA 1.458 -0.591 0 CA-C-N 118.769 1.285 . . . . 0.0 111.991 4.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.6 tp -99.96 -60.23 1.57 Allowed 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.37 1.068 . . . . 0.0 108.96 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 63.9 p -99.69 -174.59 2.75 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.95 1.3 . . . . 0.0 109.017 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -73.06 144.64 47.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 169.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.1 t -131.45 133.75 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.343 0.301 0 C-N-CA 124.418 1.087 . . . . 0.0 110.646 -176.539 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.3 m . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -140.34 152.65 45.98 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.216 1.406 . . . . 0.0 110.099 -170.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -86.96 80.87 8.29 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.46 171.15 43.42 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.97 -34.61 1.14 Allowed 'Cis proline' 0 N--CA 1.46 -0.482 0 CA-C-N 119.495 1.648 . . . . 0.0 113.515 -0.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.2 tp -121.72 -55.17 1.92 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.719 1.208 . . . . 0.0 109.889 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.5 p -99.56 176.75 5.38 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.548 1.139 . . . . 0.0 111.026 -170.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -70.31 101.58 1.95 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.543 0.737 . . . . 0.0 109.87 173.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.4 t -99.82 106.67 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 125.397 1.479 . . . . 0.0 108.545 175.008 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 N--CA 1.456 -0.16 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -140.3 141.49 35.76 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.748 1.219 . . . . 0.0 110.157 -169.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -84.96 77.0 10.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.42 165.6 38.99 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -62.19 -34.74 1.51 Allowed 'Cis proline' 0 C--N 1.346 0.414 0 CA-C-N 119.688 1.744 . . . . 0.0 113.729 1.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.1 tp -123.72 -55.96 1.7 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.709 1.204 . . . . 0.0 109.389 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.6 p -99.38 178.76 4.79 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.704 1.202 . . . . 0.0 110.193 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -65.24 121.68 15.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.655 0.382 . . . . 0.0 110.252 172.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.75 149.51 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.454 -0.254 0 C-N-CA 122.413 0.285 . . . . 0.0 111.031 -177.194 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 96.2 m . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -140.55 169.69 17.18 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.214 1.406 . . . . 0.0 110.206 -172.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -92.73 118.56 31.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.82 152.2 6.22 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.49 -45.92 0.39 Allowed 'Cis proline' 0 N--CA 1.457 -0.674 0 CA-C-N 118.888 1.344 . . . . 0.0 111.249 -0.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.6 tp -104.83 -42.22 5.42 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.202 1.401 . . . . 0.0 110.214 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.1 p -116.53 -179.83 3.79 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.18 1.392 . . . . 0.0 109.827 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -75.5 136.36 40.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -138.61 136.59 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.103 0.961 . . . . 0.0 109.297 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 N--CA 1.455 -0.207 0 C-N-CA 125.112 1.365 . . . . 0.0 108.651 169.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -140.42 144.47 36.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.706 1.202 . . . . 0.0 110.152 -170.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -85.82 66.37 9.59 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.53 153.58 25.33 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.79 -18.57 17.12 Favored 'Cis proline' 0 N--CA 1.458 -0.562 0 CA-C-N 119.186 1.493 . . . . 0.0 112.517 1.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.3 tp -139.97 -52.66 0.52 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.639 1.176 . . . . 0.0 109.226 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 p -99.35 177.0 5.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.7 1.2 . . . . 0.0 110.023 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -68.95 115.8 8.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.977 0.511 . . . . 0.0 110.267 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.66 146.25 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.453 -0.298 0 C-N-CA 122.434 0.293 . . . . 0.0 111.0 -177.147 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.1 m . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -140.46 167.62 21.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.714 1.206 . . . . 0.0 110.197 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -84.28 100.71 11.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 169.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.77 164.23 15.34 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.05 -47.84 0.29 Allowed 'Cis proline' 0 N--CA 1.46 -0.474 0 CA-C-N 119.14 1.47 . . . . 0.0 112.965 3.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tt -104.02 -59.69 1.69 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.583 1.153 . . . . 0.0 108.357 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.8 p -99.37 -176.64 3.35 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.88 1.272 . . . . 0.0 109.088 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -71.9 132.57 44.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.26 149.54 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.703 0.801 . . . . 0.0 109.243 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 N--CA 1.455 -0.188 0 C-N-CA 125.415 1.486 . . . . 0.0 108.689 171.82 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.457 -0.078 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -140.3 161.5 37.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.037 1.335 . . . . 0.0 110.202 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -98.29 98.74 9.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.15 143.42 8.46 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.57 -46.12 0.31 Allowed 'Cis proline' 0 C--N 1.347 0.459 0 CA-C-N 119.691 1.745 . . . . 0.0 111.607 -5.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 tp -140.46 36.08 1.85 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.273 1.029 . . . . 0.0 108.765 169.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -140.74 139.44 34.66 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.996 1.318 . . . . 0.0 109.257 -171.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -73.58 98.59 2.86 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.1 t -99.63 103.06 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.339 0.127 0 C-N-CA 125.178 1.391 . . . . 0.0 108.622 179.018 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -140.38 166.38 24.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.807 1.643 . . . . 0.0 109.899 -173.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -91.84 106.62 18.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.37 161.91 12.26 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.0 -40.34 1.23 Allowed 'Cis proline' 0 N--CA 1.456 -0.721 0 CA-C-N 118.727 1.264 . . . . 0.0 111.755 2.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.7 tp -104.17 -56.43 2.19 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.533 1.133 . . . . 0.0 109.682 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.2 p -107.31 -176.5 3.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.067 1.347 . . . . 0.0 110.236 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -67.18 139.41 57.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.8 t -138.64 126.54 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 t . . . . . 0 C--N 1.341 0.231 0 C-N-CA 124.716 1.207 . . . . 0.0 109.132 176.617 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 98.3 m . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -140.95 165.07 28.55 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.21 1.004 . . . . 0.0 111.526 -170.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -90.82 119.23 30.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.46 156.37 7.39 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.34 -44.64 0.48 Allowed 'Cis proline' 0 N--CA 1.456 -0.705 0 CA-C-N 118.682 1.241 . . . . 0.0 111.56 1.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tt -104.34 -55.97 2.27 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.964 1.306 . . . . 0.0 108.258 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.0 p -99.58 -176.56 3.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.068 1.347 . . . . 0.0 109.504 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -76.74 138.18 39.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 171.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.8 t -137.93 147.17 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.452 -0.334 0 C-N-CA 122.916 0.486 . . . . 0.0 110.678 174.885 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -125.19 138.23 54.13 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.741 1.216 . . . . 0.0 108.998 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -82.9 70.11 9.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.197 0.599 . . . . 0.0 109.893 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.96 148.43 16.91 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.97 -16.37 21.19 Favored 'Cis proline' 0 N--CA 1.459 -0.545 0 CA-C-N 119.32 1.56 . . . . 0.0 112.751 3.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 tp -140.05 -54.63 0.54 Allowed 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.236 1.014 . . . . 0.0 109.576 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.3 p -99.32 173.81 6.59 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.512 1.125 . . . . 0.0 110.615 -172.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -69.17 102.88 1.77 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.401 0.681 . . . . 0.0 109.63 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.52 118.26 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 125.103 1.361 . . . . 0.0 109.606 -175.534 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -140.08 139.59 35.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.856 1.262 . . . . 0.0 109.985 -169.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -85.04 60.5 6.29 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.452 0.701 . . . . 0.0 110.096 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.95 129.77 7.96 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.099 1.333 . . . . 0.0 109.983 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.65 -49.42 0.23 Allowed 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.941 1.871 . . . . 0.0 111.073 -0.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -140.9 33.58 1.77 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.103 0.961 . . . . 0.0 109.189 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.4 p -140.68 147.81 39.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.089 1.356 . . . . 0.0 108.506 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -72.9 93.15 1.68 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.755 0.422 . . . . 0.0 110.367 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.8 t -99.71 137.76 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.108 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -140.41 165.82 26.38 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.925 1.29 . . . . 0.0 110.576 -172.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -84.3 137.8 33.25 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.52 174.73 31.13 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.93 1.252 . . . . 0.0 110.808 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -60.87 -47.62 0.2 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.502 0 CA-C-N 118.822 1.311 . . . . 0.0 114.016 5.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 tt -102.18 -64.84 1.03 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.1 0.96 . . . . 0.0 108.85 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.6 p -99.56 -175.67 3.06 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.802 1.241 . . . . 0.0 109.212 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -69.6 139.28 53.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.3 t -140.04 145.04 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.311 1.044 . . . . 0.0 108.754 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m . . . . . 0 C--N 1.339 0.148 0 C-N-CA 124.393 1.077 . . . . 0.0 110.842 175.297 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.6 m . . . . . 0 N--CA 1.456 -0.166 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -140.31 172.82 12.2 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.241 1.417 . . . . 0.0 110.405 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -103.26 114.96 29.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.91 0.884 . . . . 0.0 108.779 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.49 140.31 3.49 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.73 -45.06 0.48 Allowed 'Cis proline' 0 N--CA 1.458 -0.575 0 CA-C-N 119.712 1.756 . . . . 0.0 111.457 1.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.0 tp -140.22 25.41 2.26 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.212 1.005 . . . . 0.0 109.842 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.8 p -140.62 159.85 41.3 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.409 1.483 . . . . 0.0 108.319 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -76.93 125.76 29.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.76 147.54 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.679 1.191 . . . . 0.0 108.461 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 CA--C 1.53 0.195 0 C-N-CA 124.055 0.942 . . . . 0.0 109.456 175.61 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.7 m . . . . . 0 N--CA 1.456 -0.163 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -140.73 163.76 32.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.116 1.366 . . . . 0.0 110.612 -170.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -89.12 116.44 27.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.9 156.8 7.3 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.14 -44.71 0.48 Allowed 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 118.647 1.223 . . . . 0.0 111.772 3.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.0 tp -102.03 -58.12 1.94 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.591 1.157 . . . . 0.0 109.113 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.4 p -99.88 -176.32 3.22 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.893 1.277 . . . . 0.0 109.543 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -74.81 139.31 43.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.21 152.51 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.273 1.029 . . . . 0.0 108.553 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 90.3 m . . . . . 0 C--N 1.34 0.171 0 C-N-CA 124.361 1.064 . . . . 0.0 110.213 172.829 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.2 m . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -140.48 162.48 35.24 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.015 1.326 . . . . 0.0 110.065 -172.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -85.65 111.18 19.85 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.7 155.19 7.08 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.18 -43.14 0.64 Allowed 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 118.726 1.263 . . . . 0.0 112.02 4.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tt -105.42 -58.32 1.91 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.629 1.171 . . . . 0.0 108.221 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.0 p -99.56 -178.76 3.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.038 1.335 . . . . 0.0 109.528 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -74.38 139.84 44.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 72.8 t -136.19 130.25 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.975 0.91 . . . . 0.0 109.317 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.455 -0.177 0 C-N-CA 125.576 1.55 . . . . 0.0 107.397 169.343 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.1 m . . . . . 0 C--O 1.23 0.077 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -140.52 167.78 21.35 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.606 1.562 . . . . 0.0 110.004 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -92.7 106.55 18.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.13 159.05 10.17 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.8 -39.94 1.31 Allowed 'Cis proline' 0 N--CA 1.456 -0.678 0 CA-C-N 118.674 1.237 . . . . 0.0 111.842 2.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.9 tp -105.86 -46.33 4.15 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.615 1.166 . . . . 0.0 110.42 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.4 p -122.02 -178.65 3.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.058 1.343 . . . . 0.0 110.286 -174.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -66.79 131.09 45.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.155 0.582 . . . . 0.0 110.194 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.9 t -132.24 119.16 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.9 t . . . . . 0 C--N 1.342 0.248 0 C-N-CA 124.402 1.081 . . . . 0.0 110.274 177.508 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 92.9 m . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -140.28 164.65 29.5 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.032 1.333 . . . . 0.0 110.556 -170.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -89.05 87.08 7.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.31 174.11 41.63 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.36 -41.27 0.47 Allowed 'Cis proline' 0 N--CA 1.46 -0.462 0 CA-C-N 119.312 1.556 . . . . 0.0 113.593 1.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.6 tp -113.14 -59.19 2.05 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.619 1.168 . . . . 0.0 109.572 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.7 p -99.73 179.81 4.42 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.945 1.298 . . . . 0.0 110.097 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -66.74 131.33 45.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.7 0.4 . . . . 0.0 110.498 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.5 t -133.15 118.89 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 C--N 1.34 0.174 0 C-N-CA 124.988 1.315 . . . . 0.0 108.797 173.906 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.0 m . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -140.31 175.14 9.84 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.73 1.212 . . . . 0.0 110.359 -170.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -105.98 113.27 26.71 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.31 1.044 . . . . 0.0 108.868 170.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.59 141.0 4.78 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.48 -44.26 0.58 Allowed 'Cis proline' 0 N--CA 1.458 -0.617 0 CA-C-N 119.58 1.69 . . . . 0.0 111.189 -1.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 tp -140.17 26.54 2.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.302 1.041 . . . . 0.0 109.709 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.6 p -140.78 154.28 46.2 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.532 1.533 . . . . 0.0 108.29 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -74.19 127.92 34.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -136.58 135.04 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.499 1.12 . . . . 0.0 108.908 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.455 -0.199 0 C-N-CA 124.624 1.17 . . . . 0.0 109.015 170.496 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.1 m . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -100.02 145.9 27.36 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.184 1.393 . . . . 0.0 110.075 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -85.76 76.14 9.97 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.485 0.714 . . . . 0.0 109.429 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.29 152.56 21.75 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.38 -13.82 24.35 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 118.983 1.391 . . . . 0.0 112.752 2.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.3 tp -140.08 -54.87 0.54 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.237 1.015 . . . . 0.0 109.517 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.8 p -99.58 175.87 5.68 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.571 1.148 . . . . 0.0 110.768 -173.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -71.54 100.61 2.29 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.578 0.751 . . . . 0.0 109.148 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.8 t -99.73 114.03 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.34 0.156 0 C-N-CA 124.377 1.071 . . . . 0.0 109.847 174.776 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.0 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -140.61 164.18 30.85 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.314 1.046 . . . . 0.0 110.503 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -79.23 84.99 5.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.09 176.5 39.18 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -58.91 -50.94 0.14 OUTLIER 'Cis proline' 0 CA--C 1.532 0.403 0 CA-C-N 119.037 1.419 . . . . 0.0 114.504 4.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 tp -103.06 -64.73 1.05 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.233 1.013 . . . . 0.0 109.295 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.2 p -99.58 -179.87 4.33 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.848 1.259 . . . . 0.0 108.244 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -68.13 123.58 21.07 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.017 -0.427 . . . . 0.0 110.629 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.3 t -139.06 148.22 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.4 m . . . . . 0 N--CA 1.455 -0.193 0 C-N-CA 123.904 0.881 . . . . 0.0 109.438 176.049 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.9 p . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.451 0.167 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -74.04 159.27 32.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.886 0.874 . . . . 0.0 110.967 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.9 t -99.39 68.62 1.62 Allowed 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m -111.63 91.35 3.63 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.856 1.663 . . . . 0.0 109.033 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -140.94 164.05 31.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.038 1.735 . . . . 0.0 110.041 -170.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -85.01 113.52 21.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.28 156.35 7.36 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.23 -46.32 0.37 Allowed 'Cis proline' 0 N--CA 1.458 -0.591 0 CA-C-N 118.769 1.285 . . . . 0.0 111.991 4.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.6 tp -99.96 -60.23 1.57 Allowed 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.37 1.068 . . . . 0.0 108.96 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 63.9 p -99.69 -174.59 2.75 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.95 1.3 . . . . 0.0 109.017 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 19.3 t-105 -73.06 144.64 47.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 169.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.1 t -131.45 133.75 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.5 t -140.12 91.43 2.45 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.418 1.087 . . . . 0.0 110.646 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -99.85 119.21 60.27 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.558 1.143 . . . . 0.0 108.42 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.12 84.5 2.03 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.109 2.54 . . . . 0.0 110.15 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -63.05 -64.41 0.92 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.692 0.797 . . . . 0.0 111.086 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.084 0 O-C-N 122.103 -0.373 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.4 p . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 120.387 0.137 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -81.05 60.73 4.34 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.893 0.877 . . . . 0.0 109.885 174.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -99.94 -178.9 3.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.706 1.202 . . . . 0.0 109.31 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.3 m -109.79 86.3 2.27 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.464 1.505 . . . . 0.0 108.431 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -140.34 152.65 45.98 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.216 1.406 . . . . 0.0 110.099 -170.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -86.96 80.87 8.29 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.46 171.15 43.42 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.97 -34.61 1.14 Allowed 'Cis proline' 0 N--CA 1.46 -0.482 0 CA-C-N 119.495 1.648 . . . . 0.0 113.515 -0.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.2 tp -121.72 -55.17 1.92 Allowed 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.719 1.208 . . . . 0.0 109.889 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.5 p -99.56 176.75 5.38 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.548 1.139 . . . . 0.0 111.026 -170.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -70.31 101.58 1.95 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.543 0.737 . . . . 0.0 109.87 173.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 69.4 t -99.82 106.67 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 t -140.18 71.61 1.38 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 125.397 1.479 . . . . 0.0 108.545 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -125.31 74.41 68.02 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 125.014 1.325 . . . . 0.0 108.177 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.53 109.49 2.28 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.012 2.475 . . . . 0.0 110.371 -176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -68.86 -50.73 47.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.88 0.872 . . . . 0.0 110.592 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.031 0 O-C-N 122.231 -0.293 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 111.174 0.064 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -66.21 152.0 45.79 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.435 0.694 . . . . 0.0 110.954 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -99.47 99.78 10.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.013 1.325 . . . . 0.0 108.502 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.6 m -99.83 132.16 45.35 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.149 0.98 . . . . 0.0 109.49 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.0 p-80 -140.3 141.49 35.76 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.748 1.219 . . . . 0.0 110.157 -169.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -84.96 77.0 10.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.42 165.6 38.99 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -62.19 -34.74 1.51 Allowed 'Cis proline' 0 C--N 1.346 0.414 0 CA-C-N 119.688 1.744 . . . . 0.0 113.729 1.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.1 tp -123.72 -55.96 1.7 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.709 1.204 . . . . 0.0 109.389 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.6 p -99.38 178.76 4.79 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.704 1.202 . . . . 0.0 110.193 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -65.24 121.68 15.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.655 0.382 . . . . 0.0 110.252 172.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.1 t -129.75 149.51 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 170.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.4 t -140.16 144.69 36.78 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.413 0.285 . . . . 0.0 111.031 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -140.24 170.93 8.6 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.591 1.556 . . . . 0.0 108.975 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.79 167.11 2.39 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.33 2.687 . . . . 0.0 113.698 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -54.35 -55.63 26.58 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.398 1.079 . . . . 0.0 111.554 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.056 0 O-C-N 122.313 -0.242 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.9 p . . . . . 0 N--CA 1.474 0.752 0 CA-C-O 119.854 -0.117 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -72.29 87.68 1.14 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.116 0.966 . . . . 0.0 109.322 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.5 m -99.55 99.39 10.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.782 1.233 . . . . 0.0 108.876 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 96.2 m -99.07 114.23 26.83 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.247 1.419 . . . . 0.0 109.099 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -140.55 169.69 17.18 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.214 1.406 . . . . 0.0 110.206 -172.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -92.73 118.56 31.2 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.82 152.2 6.22 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 174.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.49 -45.92 0.39 Allowed 'Cis proline' 0 N--CA 1.457 -0.674 0 CA-C-N 118.888 1.344 . . . . 0.0 111.249 -0.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.6 tp -104.83 -42.22 5.42 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.202 1.401 . . . . 0.0 110.214 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.1 p -116.53 -179.83 3.79 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.18 1.392 . . . . 0.0 109.827 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -75.5 136.36 40.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -138.61 136.59 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 124.103 0.961 . . . . 0.0 109.297 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.0 m -108.81 122.56 47.42 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.112 1.365 . . . . 0.0 108.651 169.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -99.71 109.16 54.58 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -67.81 -52.75 0.5 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.134 2.556 . . . . 0.0 111.494 -170.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 65.83 -73.31 0.07 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.543 1.937 . . . . 0.0 112.995 170.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.093 0 O-C-N 121.885 -0.51 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 120.005 -0.045 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -80.63 75.24 7.53 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.946 0.898 . . . . 0.0 108.875 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 p -99.44 100.05 11.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.843 1.257 . . . . 0.0 109.078 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.3 m -99.73 129.07 45.82 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.649 1.18 . . . . 0.0 109.232 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -140.42 144.47 36.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.706 1.202 . . . . 0.0 110.152 -170.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -85.82 66.37 9.59 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.53 153.58 25.33 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.79 -18.57 17.12 Favored 'Cis proline' 0 N--CA 1.458 -0.562 0 CA-C-N 119.186 1.493 . . . . 0.0 112.517 1.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.3 tp -139.97 -52.66 0.52 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.639 1.176 . . . . 0.0 109.226 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 59.3 p -99.35 177.0 5.33 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.7 1.2 . . . . 0.0 110.023 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -68.95 115.8 8.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.977 0.511 . . . . 0.0 110.267 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.66 146.25 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 170.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.0 t -140.1 137.85 34.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.434 0.293 . . . . 0.0 111.0 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -102.93 109.5 61.48 Favored Pre-proline 0 N--CA 1.452 -0.348 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.51 -53.84 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.621 2.214 . . . . 0.0 111.159 -173.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 67.4 -67.62 0.17 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.617 1.967 . . . . 0.0 112.605 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.093 0 O-C-N 121.781 -0.574 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 57.3 p . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 110.864 -0.05 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -54.56 147.44 14.23 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.223 1.009 . . . . 0.0 111.847 -174.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.3 p -99.37 98.05 9.03 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.283 1.433 . . . . 0.0 108.259 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.1 m -99.21 113.9 26.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.504 1.522 . . . . 0.0 109.013 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -140.46 167.62 21.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.714 1.206 . . . . 0.0 110.197 -174.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -84.28 100.71 11.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 169.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.77 164.23 15.34 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 174.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -69.05 -47.84 0.29 Allowed 'Cis proline' 0 N--CA 1.46 -0.474 0 CA-C-N 119.14 1.47 . . . . 0.0 112.965 3.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tt -104.02 -59.69 1.69 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.583 1.153 . . . . 0.0 108.357 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.8 p -99.37 -176.64 3.35 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.88 1.272 . . . . 0.0 109.088 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -71.9 132.57 44.55 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.6 t -140.26 149.54 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.703 0.801 . . . . 0.0 109.243 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.4 m -110.36 118.04 35.23 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.415 1.486 . . . . 0.0 108.689 171.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -99.67 146.43 31.82 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 109.245 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.0 133.76 37.05 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.256 2.637 . . . . 0.0 110.509 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.6 134.39 11.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.05 0 O-C-N 122.135 -0.353 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.61 0.243 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -82.27 47.81 1.19 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.912 0.885 . . . . 0.0 109.923 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 m -141.08 165.76 26.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.155 1.382 . . . . 0.0 109.46 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.3 m -107.1 92.33 4.03 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.961 1.304 . . . . 0.0 109.303 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -140.3 161.5 37.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.037 1.335 . . . . 0.0 110.202 -175.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -98.29 98.74 9.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.15 143.42 8.46 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -65.57 -46.12 0.31 Allowed 'Cis proline' 0 C--N 1.347 0.459 0 CA-C-N 119.691 1.745 . . . . 0.0 111.607 -5.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 tp -140.46 36.08 1.85 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.273 1.029 . . . . 0.0 108.765 169.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -140.74 139.44 34.66 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.996 1.318 . . . . 0.0 109.257 -171.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -73.58 98.59 2.86 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 75.1 t -99.63 103.06 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -140.4 61.88 1.51 Allowed 'General case' 0 C--N 1.339 0.127 0 C-N-CA 125.178 1.391 . . . . 0.0 108.622 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 69.3 mttm -140.27 148.06 52.56 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 125.071 1.348 . . . . 0.0 108.465 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.03 72.25 6.61 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.555 2.837 . . . . 0.0 110.011 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.39 -21.98 2.52 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.603 1.161 . . . . 0.0 112.172 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.044 0 O-C-N 121.654 -0.654 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 57.1 m . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 120.232 0.063 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -66.11 162.24 20.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.181 0.992 . . . . 0.0 110.531 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.4 t -98.81 67.92 1.72 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m -99.92 84.74 2.93 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.675 1.59 . . . . 0.0 109.423 -177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -140.38 166.38 24.85 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.807 1.643 . . . . 0.0 109.899 -173.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -91.84 106.62 18.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.37 161.91 12.26 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.0 -40.34 1.23 Allowed 'Cis proline' 0 N--CA 1.456 -0.721 0 CA-C-N 118.727 1.264 . . . . 0.0 111.755 2.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.7 tp -104.17 -56.43 2.19 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.533 1.133 . . . . 0.0 109.682 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.2 p -107.31 -176.5 3.09 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.067 1.347 . . . . 0.0 110.236 -175.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -67.18 139.41 57.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.8 t -138.64 126.54 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 t -140.66 100.45 3.86 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.716 1.207 . . . . 0.0 109.132 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -140.33 162.83 47.57 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 125.698 1.599 . . . . 0.0 109.596 -170.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.53 154.42 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.631 2.887 . . . . 0.0 112.889 170.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -57.59 -52.68 64.44 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.838 0.855 . . . . 0.0 111.239 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.086 0 O-C-N 122.327 -0.233 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.709 -0.108 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -84.41 74.74 10.32 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.028 0.931 . . . . 0.0 108.817 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.8 p -99.42 98.25 9.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.939 0.895 . . . . 0.0 110.081 -169.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.85 117.85 35.03 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.851 1.26 . . . . 0.0 108.382 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -140.95 165.07 28.55 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.21 1.004 . . . . 0.0 111.526 -170.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -90.82 119.23 30.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.46 156.37 7.39 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.34 -44.64 0.48 Allowed 'Cis proline' 0 N--CA 1.456 -0.705 0 CA-C-N 118.682 1.241 . . . . 0.0 111.56 1.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 tt -104.34 -55.97 2.27 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.964 1.306 . . . . 0.0 108.258 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.0 p -99.58 -176.56 3.31 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.068 1.347 . . . . 0.0 109.504 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -76.74 138.18 39.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 171.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.8 t -137.93 147.17 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.44 145.02 44.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.916 0.486 . . . . 0.0 110.678 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.27 86.24 17.2 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 170.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -81.71 65.05 8.62 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.442 2.761 . . . . 0.0 110.171 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -107.72 150.07 27.39 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.583 1.153 . . . . 0.0 110.296 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.088 0 O-C-N 122.208 -0.308 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 N--CA 1.474 0.772 0 CA-C-O 120.355 0.122 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -74.93 72.17 2.09 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.499 1.12 . . . . 0.0 109.107 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.5 m -140.38 -163.64 1.56 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.746 1.619 . . . . 0.0 109.109 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 10.2 m -101.96 149.98 23.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.621 0.768 . . . . 0.0 109.706 173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -125.19 138.23 54.13 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.741 1.216 . . . . 0.0 108.998 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -82.9 70.11 9.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.197 0.599 . . . . 0.0 109.893 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.96 148.43 16.91 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.97 -16.37 21.19 Favored 'Cis proline' 0 N--CA 1.459 -0.545 0 CA-C-N 119.32 1.56 . . . . 0.0 112.751 3.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 tp -140.05 -54.63 0.54 Allowed 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.236 1.014 . . . . 0.0 109.576 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.3 p -99.32 173.81 6.59 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.512 1.125 . . . . 0.0 110.615 -172.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -69.17 102.88 1.77 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.401 0.681 . . . . 0.0 109.63 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.52 118.26 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.2 m -99.83 109.81 22.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.103 1.361 . . . . 0.0 109.606 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -140.03 154.65 70.6 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.979 1.312 . . . . 0.0 109.076 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.53 77.48 3.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.506 2.804 . . . . 0.0 109.959 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -68.57 -58.25 4.55 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.453 0.701 . . . . 0.0 109.823 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.06 0 CA-C-N 116.672 -0.24 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 120.282 0.087 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -79.77 72.93 6.51 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.724 1.21 . . . . 0.0 109.409 -176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.0 m -99.83 -178.84 3.99 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.624 1.17 . . . . 0.0 110.189 -175.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m -99.32 132.57 44.55 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -140.08 139.59 35.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.856 1.262 . . . . 0.0 109.985 -169.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -85.04 60.5 6.29 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.452 0.701 . . . . 0.0 110.096 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -120.95 129.77 7.96 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.099 1.333 . . . . 0.0 109.983 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.65 -49.42 0.23 Allowed 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.941 1.871 . . . . 0.0 111.073 -0.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 tp -140.9 33.58 1.77 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.103 0.961 . . . . 0.0 109.189 171.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.4 p -140.68 147.81 39.84 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 125.089 1.356 . . . . 0.0 108.506 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -72.9 93.15 1.68 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.755 0.422 . . . . 0.0 110.367 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.8 t -99.71 137.76 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 172.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.6 t -140.06 72.45 1.4 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -124.02 162.69 39.98 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.084 1.754 . . . . 0.0 108.397 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -49.98 110.02 0.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.795 2.997 . . . . 0.0 113.217 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -78.75 -58.86 3.03 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.913 0.885 . . . . 0.0 110.202 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.055 0 O-C-N 122.214 -0.304 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 47.4 p . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 120.254 0.073 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -155.28 175.17 14.21 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.56 1.144 . . . . 0.0 109.861 177.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 t -140.16 171.46 14.15 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.349 1.06 . . . . 0.0 109.526 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.0 m -140.1 155.37 47.04 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.246 1.019 . . . . 0.0 109.971 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -140.41 165.82 26.38 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.925 1.29 . . . . 0.0 110.576 -172.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -84.3 137.8 33.25 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 169.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.52 174.73 31.13 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.93 1.252 . . . . 0.0 110.808 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -60.87 -47.62 0.2 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.502 0 CA-C-N 118.822 1.311 . . . . 0.0 114.016 5.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 tt -102.18 -64.84 1.03 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.1 0.96 . . . . 0.0 108.85 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.6 p -99.56 -175.67 3.06 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.802 1.241 . . . . 0.0 109.212 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -69.6 139.28 53.64 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 169.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.3 t -140.04 145.04 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.311 1.044 . . . . 0.0 108.754 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -101.61 150.94 22.58 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.393 1.077 . . . . 0.0 110.842 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -118.92 75.76 13.96 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 125.142 1.377 . . . . 0.0 108.89 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.35 107.92 1.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.309 2.673 . . . . 0.0 110.295 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -69.92 -52.83 21.34 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.809 0.844 . . . . 0.0 110.364 -177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.03 0 O-C-N 122.285 -0.259 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -179.07 176.38 0.89 Allowed 'General case' 0 C--N 1.34 0.175 0 C-N-CA 125.53 1.532 . . . . 0.0 109.573 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.1 t -138.83 116.82 11.66 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 169.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 62.6 m -99.44 124.33 44.49 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -140.31 172.82 12.2 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.241 1.417 . . . . 0.0 110.405 -169.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -103.26 114.96 29.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.91 0.884 . . . . 0.0 108.779 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.49 140.31 3.49 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -75.73 -45.06 0.48 Allowed 'Cis proline' 0 N--CA 1.458 -0.575 0 CA-C-N 119.712 1.756 . . . . 0.0 111.457 1.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.0 tp -140.22 25.41 2.26 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.212 1.005 . . . . 0.0 109.842 174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.8 p -140.62 159.85 41.3 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.409 1.483 . . . . 0.0 108.319 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -76.93 125.76 29.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.76 147.54 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.679 1.191 . . . . 0.0 108.461 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.3 t -140.44 161.29 38.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.055 0.942 . . . . 0.0 109.456 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -129.46 77.69 76.9 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.053 0.941 . . . . 0.0 112.29 -169.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -47.19 120.98 4.75 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.227 3.285 . . . . 0.0 111.928 170.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -153.07 168.86 24.5 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.737 0.815 . . . . 0.0 110.578 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.087 0 O-C-N 122.128 -0.357 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 35.5 p . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.29 0.091 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -112.97 85.46 2.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.299 1.44 . . . . 0.0 107.793 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.2 t -98.96 95.15 6.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -170.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.7 m -99.32 116.99 32.77 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.5 1.52 . . . . 0.0 108.672 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -140.73 163.76 32.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.116 1.366 . . . . 0.0 110.612 -170.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -89.12 116.44 27.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.9 156.8 7.3 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.14 -44.71 0.48 Allowed 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 118.647 1.223 . . . . 0.0 111.772 3.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.0 tp -102.03 -58.12 1.94 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.591 1.157 . . . . 0.0 109.113 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.4 p -99.88 -176.32 3.22 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.893 1.277 . . . . 0.0 109.543 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -74.81 139.31 43.18 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 169.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -140.21 152.51 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.273 1.029 . . . . 0.0 108.553 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 90.3 m -122.71 151.51 41.48 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.361 1.064 . . . . 0.0 110.213 172.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -125.6 89.65 52.07 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.165 1.386 . . . . 0.0 108.65 172.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -64.24 175.69 3.12 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.076 3.184 . . . . 0.0 112.587 172.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -77.57 71.42 4.06 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 170.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.077 0 O-C-N 122.145 -0.347 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 111.369 0.137 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -98.34 168.05 10.46 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.142 0.977 . . . . 0.0 109.98 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -99.39 87.78 3.71 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.2 m -98.93 105.3 17.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.313 1.445 . . . . 0.0 107.924 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -140.48 162.48 35.24 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.015 1.326 . . . . 0.0 110.065 -172.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -85.65 111.18 19.85 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 169.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.7 155.19 7.08 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.18 -43.14 0.64 Allowed 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 118.726 1.263 . . . . 0.0 112.02 4.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tt -105.42 -58.32 1.91 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.629 1.171 . . . . 0.0 108.221 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.0 p -99.56 -178.76 3.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.038 1.335 . . . . 0.0 109.528 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -74.38 139.84 44.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 72.8 t -136.19 130.25 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.975 0.91 . . . . 0.0 109.317 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.7 m -105.3 103.41 12.94 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 125.576 1.55 . . . . 0.0 107.397 169.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -99.26 107.54 45.21 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.8 123.73 11.06 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.103 1.869 . . . . 0.0 110.409 -177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -77.08 -54.2 6.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.804 0.842 . . . . 0.0 109.979 -176.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.011 0 O-C-N 122.337 -0.227 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 120.3 0.095 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -147.79 159.44 43.83 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.668 1.187 . . . . 0.0 110.29 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -113.25 74.57 0.87 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.945 1.298 . . . . 0.0 108.385 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.1 m -103.83 86.02 2.52 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.077 1.351 . . . . 0.0 109.473 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -140.52 167.78 21.35 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.606 1.562 . . . . 0.0 110.004 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -92.7 106.55 18.5 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 169.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.13 159.05 10.17 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.8 -39.94 1.31 Allowed 'Cis proline' 0 N--CA 1.456 -0.678 0 CA-C-N 118.674 1.237 . . . . 0.0 111.842 2.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.9 tp -105.86 -46.33 4.15 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.615 1.166 . . . . 0.0 110.42 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 82.4 p -122.02 -178.65 3.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.058 1.343 . . . . 0.0 110.286 -174.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -66.79 131.09 45.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.155 0.582 . . . . 0.0 110.194 172.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.9 t -132.24 119.16 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.9 t -140.99 129.34 22.38 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.402 1.081 . . . . 0.0 110.274 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.7 mttp -130.25 82.0 66.92 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.522 1.529 . . . . 0.0 107.13 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -81.83 66.35 8.45 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.643 2.896 . . . . 0.0 111.27 -169.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 53.61 55.59 8.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.19 1.396 . . . . 0.0 111.286 176.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.055 0 O-C-N 122.133 -0.354 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 121.108 0.48 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -67.0 121.6 15.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.921 0.888 . . . . 0.0 110.43 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.5 t -99.11 78.18 2.23 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 92.9 m -99.83 84.97 2.99 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.037 1.335 . . . . 0.0 108.628 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -140.28 164.65 29.5 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.032 1.333 . . . . 0.0 110.556 -170.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -89.05 87.08 7.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.31 174.11 41.63 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -60.36 -41.27 0.47 Allowed 'Cis proline' 0 N--CA 1.46 -0.462 0 CA-C-N 119.312 1.556 . . . . 0.0 113.593 1.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.6 tp -113.14 -59.19 2.05 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.619 1.168 . . . . 0.0 109.572 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.7 p -99.73 179.81 4.42 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.945 1.298 . . . . 0.0 110.097 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -66.74 131.33 45.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.7 0.4 . . . . 0.0 110.498 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.5 t -133.15 118.89 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 174.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.7 t -141.03 116.42 10.08 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.988 1.315 . . . . 0.0 108.797 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -140.53 152.23 65.8 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.415 1.086 . . . . 0.0 109.335 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -81.52 62.97 8.49 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.345 2.697 . . . . 0.0 110.812 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -81.02 72.37 8.05 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.015 0.926 . . . . 0.0 110.254 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.091 0 O-C-N 121.98 -0.45 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 119.89 -0.1 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -70.14 81.02 0.51 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.838 1.255 . . . . 0.0 109.94 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.9 p -98.89 92.01 5.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.272 1.029 . . . . 0.0 108.498 -173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.0 m -99.12 119.33 37.67 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.018 0.927 . . . . 0.0 108.518 -175.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -140.31 175.14 9.84 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.73 1.212 . . . . 0.0 110.359 -170.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -105.98 113.27 26.71 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.31 1.044 . . . . 0.0 108.868 170.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.59 141.0 4.78 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.48 -44.26 0.58 Allowed 'Cis proline' 0 N--CA 1.458 -0.617 0 CA-C-N 119.58 1.69 . . . . 0.0 111.189 -1.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 tp -140.17 26.54 2.2 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.302 1.041 . . . . 0.0 109.709 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.6 p -140.78 154.28 46.2 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.532 1.533 . . . . 0.0 108.29 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -74.19 127.92 34.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 172.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.9 t -136.58 135.04 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 124.499 1.12 . . . . 0.0 108.908 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.9 t -140.62 161.84 36.8 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.624 1.17 . . . . 0.0 109.015 170.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.13 148.8 56.01 Favored Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.279 1.031 . . . . 0.0 109.943 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -82.73 67.35 7.89 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.708 2.939 . . . . 0.0 111.062 -173.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 72.62 -60.4 0.53 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.237 1.815 . . . . 0.0 112.881 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.099 0 O-C-N 121.772 -0.58 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 74.2 p . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -76.9 45.86 0.44 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.638 0.775 . . . . 0.0 111.133 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.6 t -99.76 81.92 2.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.1 m -98.68 72.48 2.0 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -174.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -100.02 145.9 27.36 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.184 1.393 . . . . 0.0 110.075 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -85.76 76.14 9.97 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.485 0.714 . . . . 0.0 109.429 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.29 152.56 21.75 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.38 -13.82 24.35 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 118.983 1.391 . . . . 0.0 112.752 2.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.3 tp -140.08 -54.87 0.54 Allowed 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.237 1.015 . . . . 0.0 109.517 176.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.8 p -99.58 175.87 5.68 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.571 1.148 . . . . 0.0 110.768 -173.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -71.54 100.61 2.29 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.578 0.751 . . . . 0.0 109.148 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.8 t -99.73 114.03 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 t -140.74 159.46 42.15 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.377 1.071 . . . . 0.0 109.847 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -140.36 79.41 21.01 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.13 107.87 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.166 3.244 . . . . 0.0 113.123 -175.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -75.25 172.9 11.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.362 1.065 . . . . 0.0 111.122 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.087 0 O-C-N 122.001 -0.437 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 47.2 p . . . . . 0 N--CA 1.475 0.801 0 CA-C-O 120.737 0.303 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -145.29 21.14 1.55 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.675 1.19 . . . . 0.0 110.623 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 p -99.63 -58.7 1.87 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.332 1.453 . . . . 0.0 107.205 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.0 m -138.26 109.97 7.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.855 2.062 . . . . 0.0 106.273 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -140.61 164.18 30.85 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.314 1.046 . . . . 0.0 110.503 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -79.23 84.99 5.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 169.09 176.5 39.18 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -58.91 -50.94 0.14 OUTLIER 'Cis proline' 0 CA--C 1.532 0.403 0 CA-C-N 119.037 1.419 . . . . 0.0 114.504 4.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.4 tp -103.06 -64.73 1.05 Allowed 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.233 1.013 . . . . 0.0 109.295 179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 77.2 p -99.58 -179.87 4.33 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.848 1.259 . . . . 0.0 108.244 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -68.13 123.58 21.07 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.017 -0.427 . . . . 0.0 110.629 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.3 t -139.06 148.22 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.4 m -99.55 75.99 1.98 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.904 0.881 . . . . 0.0 109.438 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -140.36 161.52 54.61 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 125.664 1.586 . . . . 0.0 108.849 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.45 75.47 1.96 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.759 2.973 . . . . 0.0 109.445 170.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 55.68 48.64 18.02 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.36 1.464 . . . . 0.0 110.882 -174.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.107 0 CA-C-N 115.873 -0.603 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_